Non-Insured Health Benefits program: Annual report 2024-2025

PDF Version (3.6 Mb, 114 Pages)

Table of contents

1. Overview

Introduction

Indigenous Services Canada (ISC)'s Non-Insured Health Benefits (NIHB) program is a national program that provides eligible registered First Nations and recognized Inuit with coverage for a range of medically necessary health benefits when these benefits are not otherwise covered through private or provincial or territorial health insurance plans or social programs.

NIHB program benefits include prescription drugs and select over-the-counter (OTC) medications, dental and vision care, medical supplies and equipment (MS&E), mental health counselling and medical transportation to access medically required health services that are not available on the reserve or in the community of residence. This report covers the 2024-2025 fiscal year. A fiscal year runs from April 1 to March 31. During 2024-2025, NIHB provided access to benefits coverage for 983,461 eligible clients.

Now in its 31st edition, the 2024-2025 NIHB Annual report provides national and regional data on NIHB client population, expenditures, benefit types and benefit utilization. This report is published in accordance with the NIHB program's performance management responsibilities and is intended for the following target audiences:

  • First Nations and Inuit organizations and governments at community, regional and national levels
  • Regional and headquarters managers and staff of Indigenous Services Canada
  • Others in government and in non-government organizations with an interest in the provision of health services to First Nations and Inuit communities

2. Client population

To be eligible for the NIHB program, a client must be a resident of Canada and 1 of the following:

Some clients receive their health benefit coverage directly from a First Nations or Inuit government, community or health authority. This applies to:

As of March 31, 2025, 983,461 First Nations and Inuit clients were eligible to receive benefits under the NIHB program, an increase of 2.5% from March 2024.

First Nations and Inuit population data are drawn from the Status Verification System (SVS), which is operated by the NIHB program. SVS data on First Nations clients are based on information provided by Indigenous Services Canada. SVS data on Inuit clients are based on information provided by the Governments of Northwest Territories and Nunavut as well as Inuit organizations including the Inuvialuit Regional Corporation, Nunavut Tunngavik Incorporated and the Makivik Corporation.

Eligible client population by region March 2025

Ontario had the largest number of eligible clients, at 24.3% of the national total, followed by Manitoba and Saskatchewan with 17.8% each.

Population values are based on region of band registration, which is not necessarily the client's current region of residence. The majority of British Columbia clients previously covered by the NIHB program are now covered by the British Columbia First Nations Health Authority and are not represented in this chart. The remaining NIHB clients in British Columbia are Inuit clients or clients associated with British Columbia bands but residing in other provinces and territories of Canada, where they are covered under the NIHB program.

Figure 2.1: Eligible client population by region

Source: SVS adapted by Program Analytics and Risk Mitigation

Text alternative for Figure Figure 2.1: Eligible client population by region

This image is a map of Canada with the following population values:

  • Atlantic has 72,034
  • Quebec has 89,487
  • Ontario has 239,025
  • Manitoba has 174,827
  • Saskatchewan has 175,529
  • Alberta has 137,275
  • British Columbia has 19,342
  • Yukon has 8,004
  • Northwest Territories has 28,764
  • Nunavut has 39,174
  • Total eligible population is 983,461

Eligible population by client type and region March 2024 and March 2025

Of the 983,461 total eligible clients at the end of the 2024-2025 fiscal year, 929,270 (94.5%) were First Nations clients while 54,191 (5.5%) were Inuit clients. The number of First Nations clients increased by 2.6% and the number of Inuit clients increased by 1.8% over the previous year.

From March 2024 to March 2025, British Columbia had the highest percentage change in total eligible clients with a 3.9% increase, followed by Quebec and Saskatchewan with increases of 3.5% and 3.4% respectively.

Table 2.1: Eligible population by client type and region
Region First Nations Inuit Total % Change
March 2024 March 2025 March 2024 March 2025 March 2024 March 2025 2024-2025
Atlantic 70,308 71,554 464 480 70,772 72,034 1.8%
Quebec 84,372 87,340 2,057 2,147 86,429 89,487 3.5%
Ontario 232,165 238,013 975 1,012 233,140 239,025 2.5%
Manitoba 170,074 174,553 262 274 170,336 174,827 2.6%
Saskatchewan 169,728 175,415 104 114 169,832 175,529 3.4%
Alberta 134,339 136,405 829 870 135,168 137,275 1.6%
British Columbia 18,179 18,903 433 439 18,612 19,342 3.9%
Yukon 7,775 7,848 157 156 7,932 8,004 0.9%
Northwest Territories 19,050 19,239 9,402 9,525 28,452 28,764 1.1%
Nunavut 0 0 38,534 39,174 38,534 39,174 1.7%
National 905,990 929,270 53,217 54,191 959,207 983,461 2.5%
Source: SVS adapted by Program Analytics and Risk Mitigation

Eligible client population over time: March 2016 to March 2025

Over the past 10 years, the total number of eligible clients in SVS has increased by 17.2%, from 839,129 in March 2016 to 983,461 in March 2025.

Chart 2.1: Eligible client population, March 2016 to March 2025

Source: SVS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 2.1: Eligible client population, March 2016 to March 2025

This image is a bar graph which visually describes NIHB eligible population growth over ten years as follows:

  • 2016 was 839,129
  • 2017 was 853,088
  • 2018 was 867,749
  • 2019 was 873,312
  • 2020 was 887,518
  • 2021 was 898,839
  • 2022 was 915,895
  • 2023 was 936,006
  • 2024 was 959,207
  • 2025 was 983,461

Over the past 5 years, the NIHB program's total number of eligible clients increased by 7.9% from 898,839 in March 2021 to 983,461 in March 2025. Quebec had the largest increase in eligible clients over this period, with a growth rate of 17.6%. British Columbia and Saskatchewan followed with growth rates of 13.6% and 10.5% respectively.

Table 2.2: Eligible client population by region, March 2021 to March 2025
Region March 2021 March 2022 March 2023 March 2024 March 2025
Atlantic 66,782 68,277 69,589 70,772 72,034
Quebec 76,085 79,715 83,279 86,429 89,487
Ontario 218,784 223,709 228,734 233,140 239,025
Manitoba 160,954 162,588 165,855 170,336 174,827
Saskatchewan 158,785 161,518 165,347 169,832 175,529
Alberta 128,230 129,657 131,796 135,168 137,275
British Columbia 17,019 17,622 17,897 18,612 19,342
Yukon 7,742 7,801 7,852 7,932 8,004
Northwest Territories 27,847 27,956 28,233 28,452 28,764
Nunavut 36,611 37,026 37,418 38,534 39,174
Total 898,839 915,895 936,006 959,207 983,461
Annual % change 1.3% 1.9% 2.2% 2.5% 2.5%
Source: SVS adapted by Program Analytics and Risk Mitigation

Annual population growth, eligible client population and population of Canada 2016 to 2025

Over the previous 10 years, the NIHB eligible client population has grown faster than the population of Canada. From 2016 to 2025, the population of Canada increased by 12.8% while the NIHB eligible First Nations and Inuit client population increased by 16.4%.

Chart 2.2: Annual population growth, eligible client population and population of Canada

Source: SVS and Statistics Canada Catalogue No. 91-002-XWE, Quarterly Demographic Statistics, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 2.2: Annual population growth, eligible client population and population of Canada.

This image is a line graph that visually describes annual population growth for the NIHB eligible population and for the Canadian population.

Year 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
NIHB client population 839,129 853,088 867,749 873,312 887,518 898,839 915,895 936,006 959,207 983,461
Growth rate 1.8% 1.7% 1.7% 0.6% 1.6% 1.3% 1.9% 2.2% 2.5% 2.5%
Canadian population 35,832,513 36,264,604 36,708,083 37,058,856 37,618,495 38,028,638 38,239,864 38,935,934 40,083,484 41,288,599
Growth rate 0.8% 1.2% 1.2% 1.0% 1.5% 1.1% 0.6% 1.8% 2.9% 3.0%

Eligible client population by age group, gender and region March 2025

The NIHB program recognizes the importance of representative data for our gender diverse client population. As of 2020, clients can choose Male, Female or Another gender as a gender identifier when applying for or updating their registration with Indigenous Services Canada, which is captured in population and benefit utilization data. Given that the number of individuals choosing Another gender is small, data aggregation to a 2-category gender variable is sometimes necessary to protect the confidentiality of responses provided, in keeping with government practices for safeguarding the privacy of individuals. In these cases, individuals in the category Another gender are randomly distributed into the other 2 gender categories and are denoted by the+ symbol.

  • male+ includes men and boys as well as some non-binary persons
  • female+ includes women and girls as well as some non-binary persons

Of the 983,461 NIHB eligible clients on the SVS as of March 31, 2025, 49.3% were male, 50.7% were female, and a small percentage of clients were another gender (329).

The average age of the eligible client population was 36 years of age. By region, this average ranged from a low of 29 in Nunavut to a high of 42 in British Columbia.

The average age of the male and female eligible client population was 35 and 37 years, respectively. The average age for males ranged from a low of 29 in Nunavut to a high of 41 in British Columbia. The average age for females varied from a low of 29 in Nunavut to a high of 44 in British Columbia. The average age for clients choosing Another gender was 24 years.

Table 2.3: Eligible client population by age group, gender and region

Source: SVS adapted by Program Analytics and Risk Mitigation

Table 2.3.1: Atlantic region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 1,181 1,976 2,349 2,810 2,742 2,773 2,893 2,619 2,350 2,211 2,354 2,329 2,074 4,758 35,419
Female+ 1,101 1,861 2,355 2,690 2,567 2,750 2,840 2,533 2,416 2,261 2,351 2,525 2,361 6,004 36,615
Total 2,282 3,837 4,704 5,500 5,309 5,523 5,733 5,152 4,766 4,472 4,705 4,854 4,435 10,762 72,034
Average age: 39 (Male+: 38, Female+: 40)
Table 2.3.2: Quebec region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 1,184 2,599 3,201 3,731 3,433 3,564 3,775 3,224 2,940 2,695 2,542 2,534 2,587 5,729 43,738
Female+ 1,076 2,419 3,081 3,524 3,274 3,445 3,674 3,293 2,922 2,673 2,682 2,826 2,861 7,999 45,749
Total 2,260 5,018 6,282 7,255 6,707 7,009 7,449 6,517 5,862 5,368 5,224 5,360 5,448 13,728 89,487
Average age: 39 (Male+: 38, Female+: 40)
Table 2.3.3: Ontario region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 2,986 6,305 8,493 9,536 9,478 9,843 10,081 8,981 7,734 7,189 7,021 7,041 6,756 15,074 116,518
Female+ 2,803 5,870 8,221 9,160 9,145 9,498 9,932 8,857 8,069 7,429 7,373 7,499 7,636 21,015 122,507
Total 5,789 12,176 16,714 18,696 18,623 19,341 20,013 17,838 15,803 14,618 14,394 14,540 14,392 36,089 239,025
Average age: 39 (Male+: 38, Female+: 41)
Table 2.3.4: Manitoba region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 3,540 7,271 8,802 9,165 8,096 7,831 7,759 6,388 5,303 4,600 4,427 4,220 3,524 6,123 87,049
Female+ 3,358 6,952 8,373 9,091 7,617 7,473 7,725 6,346 5,216 4,597 4,701 4,434 3,959 7,936 87,778
Total 6,898 14,223 17,175 18,256 15,713 15,304 15,484 12,734 10,519 9,197 9,128 8,654 7,483 14,059 174,827
Average age: 33 (Male+: 32, Female+: 34)
Table 2.3.5: Saskatchewan region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 4,300 7,174 8,504 9,310 8,146 7,742 7,880 6,866 5,568 4,625 4,268 3,997 3,213 5,197 86,790
Female+ 4,185 6,985 8,327 8,993 8,024 7,663 7,842 6,755 5,482 4,745 4,572 4,332 3,694 7,140 88,739
Total 8,485 14,159 16,831 18,303 16,170 15,405 15,722 13,621 11,050 9,370 8,840 8,329 6,907 12,337 175,529
Average age: 32 (Male+: 31, Female+: 33)
Table 2.3.6: Alberta region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 3,147 5,650 6,901 7,379 6,454 6,195 6,073 5,209 4,236 3,564 3,208 2,997 2,504 4,443 67,960
Female+ 2,859 5,492 6,539 7,093 6,206 5,878 5,849 5,178 4,441 3,747 3,513 3,265 2,931 6,324 69,315
Total 6,006 11,141 13,440 14,472 12,660 12,073 11,922 10,387 8,677 7,311 6,721 6,262 5,435 10,767 137,275
Average age: 33 (Male+: 32, Female+: 34)
Table 2.3.7: British Columbia region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 119 295 415 607 712 844 858 892 811 654 679 579 535 1,196 9,196
Female+ 142 281 420 587 670 773 863 821 819 726 654 728 696 1,966 10,146
Total 261 576 835 1,194 1,382 1,617 1,721 1,713 1,630 1,380 1,333 1,307 1,231 3,162 19,342
Average age: 42 (Male+: 41, Female+: 44)
Table 2.3.8: Yukon region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 92 191 251 280 303 308 342 305 291 260 268 294 307 491 3,983
Female+ 83 208 222 228 284 297 332 303 292 211 248 259 335 719 4,021
Total 175 399 473 508 587 605 674 608 583 471 516 553 642 1,210 8,004
Average age: 41 (Male+: 40, Female+: 42)
Table 2.3.9: Northwest Territories region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 463 859 1,006 1,144 1,007 1,136 1,448 1,224 1,068 848 890 896 757 1,399 14,145
Female+ 425 773 990 1,036 1,061 1,137 1,438 1,244 1,021 923 890 942 897 1,842 14,619
Total 888 1,632 1,996 2,180 2,068 2,273 2,886 2,468 2,089 1,771 1,780 1,838 1,654 3,241 28,764
Average age: 38 (Male+: 37, Female+: 39)
Table 2.3.10: Nunavut region
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 1,719 2,154 2,087 2,018 1,838 1,622 1,537 1,363 1,084 886 811 800 618 1,112 19,649
Female+ 1,726 2,048 2,029 2,012 1,697 1,573 1,532 1,346 1,057 949 841 838 659 1,218 19,525
Total 3,445 4,202 4,116 4,030 3,535 3,195 3,069 2,709 2,141 1,835 1,652 1,638 1,277 2,330 39,174
Average age: 29 (Male+: 29, Female+: 29)
Table 2.3.11: Total of all regions
  Age group Total
0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+
Male+ 18,731 34,474 42,009 45,980 42,209 41,858 42,646 37,071 31,385 27,532 26,468 25,687 22,875 45,522 484,447
Female+ 17,758 32,889 40,557 44,414 40,545 40,487 42,027 36,676 31,735 28,261 27,825 27,648 26,029 62,163 499,014
Total 36,489 67,363 82,566 90,394 82,754 82,345 84,673 73,747 63,120 55,793 54,293 53,335 48,904 107,685 983,461
Average age: 36 (Male+: 35, Female+: 37)

Population analysis by age group March 2025

The overall NIHB client population is relatively young compared to the general population of Canada. The share of the NIHB client population under 20 years of age was 28.1% compared to 20.8% for the population of Canada. Nearly two-thirds (61.0%) of eligible clients are under the age of 40, compared to 49.6% for the population of Canada. The average age of NIHB clients is 36 compared to 40 years of age for the population of Canada.

Chart 2.3: Proportion of population of Canada and of the NIHB client population by age group

Source: SVS and Statistics Canada CANSIM table 051-0001, Population by age and sex group, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 2.3: Proportion of population of Canada and of the NIHB client population by age group

This image is a bar graph that visually describes the proportion of the population of Canada and the NIHB eligible population by age group, as follows:

  • the percentage of the population of Canada aged 0 to 9 is 9.8%
  • the percentage of the NIHB population aged 0 to 9 is 10.6%
  • the percentage of the population of Canada aged 10 to 19 is 11.0%
  • the percentage of the NIHB population aged 10 to 19 is 17.6%
  • the percentage of the population of Canada aged 20 to 29 is 14.0%
  • the percentage of the NIHB population aged 20 to 29 is 16.8%
  • the percentage of the population of Canada aged 30 to 39 is 14.8%
  • the percentage of the NIHB population aged 30 to 39 is 16.1%
  • the percentage of the population of Canada aged 40 to 49 is 12.9%
  • the percentage of the NIHB population aged 40 to 49 is 12.1%
  • the percentage of the population of Canada aged 50 to 59 is 12.0%
  • the percentage of the NIHB population aged 50 to 59 is 10.9%
  • the percentage of the population of Canada aged 60 and over is 25.5%
  • the percentage of the NIHB population aged 60 and over is 15.9%

3. NIHB program benefit expenditures

Factors influencing NIHB program sustainability 2024-2025

Cost and service pressures on the Canadian health system have been linked to factors such as an aging population and the increased demand for and utilization of health goods, particularly pharmaceuticals and services. In addition to these factors, NIHB program expenditures are driven by the number of eligible clients and their medical needs. A significant proportion of NIHB clients live in small and remote communities and require medical transportation to access health services that are not available locally.

Factors that influence NIHB program sustainability include population, market and professional practice changes including:

  • changing demographics, including population growth and registration and an aging population
  • health status, including disease burden and prevalence of chronic and infectious diseases
  • geographic distribution of client population and accessibility of health services
  • advancements in medical research and evidence, treatments and health technologies
  • input received from First Nations and Inuit partners
  • introduction of newer high-cost therapies and procedures
  • changes in health professional fees and scope of practice
  • provincial/Territorial health insurance decisions
  • shift from insured hospital treatments to non-insured coverage
  • economic factors which cause increases in the price of fuel, food and meals and accommodations
  • insurance industry dynamics

NIHB expenditures by benefit ($ millions) 2024-2025

In 2024-2025, total NIHB program benefit expenditures were $2,330.7 million. This represents an increase of 11.1% over NIHB expenditures of $2,098.2 million in 2023-2024. Medical transportation costs represented the largest proportion of expenditures at 37.8% ($880.2 million), followed by pharmacy benefit costs at 30.4% ($708.1 million) and dental benefit costs at 18.2% ($425.0 million).

NIHB medical transportation, pharmacy and dental benefit expenditures accounted for 86.4% of all NIHB expenditures in 2024-2025.

Chart 3.1: NIHB expenditures by benefit ($ millions)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 3.1: NIHB expenditures by benefit ($ millions)

This image is a pie chart visually describing NIHB expenditures in millions and proportion of total by benefit area for fiscal year 2024-2025, as follows.

  • total expenditure for medical transportation is $880.2 and proportion of total expenditures is 37.8%
  • total expenditure for pharmacy is $708.1 and proportion of total expenditures is 30.4%
  • total expenditure for dental is $425.0 and proportion of total expenditures is 18.2%
  • total expenditure for medical supplies and equipment is $84.0 and proportion of total expenditures is 3.6%
  • total expenditure for mental health counselling is $132.6 and proportion of total expenditures is 5.7%
  • total expenditure for vision care is $52.4 and proportion of total expenditures is 2.2%
  • total expenditure for other is $48.4 and proportion of total expenditures is 2.1%

Approximately $71.8 million in administration costs are not reflected in the $2,330.7 million in NIHB expenditures. More detail is provided in section 11.

NIHB expenditures and growth by benefit 2024-2025

NIHB program benefit expenditures increased by 11.1%, or $232.4 million from fiscal year 2023-2024. The highest net increase in expenditures were in the NIHB medical transportation and pharmacy benefits at $90.6 and $59.5 million, respectively. Factors affecting benefit expenditure growth are discussed in subsequent sections of this report.

Table 3.1: NIHB expenditures and growth by benefit
Benefit Total expenditures (Hundred Thousands of dollars) 2023-2024 Total expenditures (Hundred Thousands of dollars) 2024-2025 Percentage change from 2023-2024
Medical transportation $789,621 $880,222 11.5%
Pharmacy $648,600 $708,069 9.2%
MS&E $75,131 $84,011 11.8%
Dental $379,940 $425,024 11.9%
Vision care $52,038 $52,356 0.6%
Mental health counselling $117,425 $132,565 12.9%
Other $35,462 $48,411 36.5%
Total expenditures $2,098,218 $2,330,658 11.1%
Source: FST adapted by Program Analytics and Risk Mitigation Division

Expenditures in the other category include:

  • program oversight including costs for claims processing through the Health Information and Claims Processing Services (HICPS) system
  • supplementary funding for the BC First Nations Health Authority for additional clients who became eligible after the transfer of responsibilities due to changes in federal legislation
  • contribution agreements to support engagement with Indigenous partner organizations
  • NIHB navigators

NIHB expenditures by benefit and region (Hundred Thousands of dollars) 2024-2025

Manitoba accounted for the highest proportion of total expenditures at $573.1 million, or 24.6% of the national total, followed by Ontario at $454.0 million (19.5%), and Saskatchewan at $447.4 million (19.2%). By comparison, the lowest expenditures were in the Atlantic region at $113.5 million (4.9%).

Headquarters expenditures represent costs paid for claims processing services, as well as operational expenditures associated with NIHB program oversight and policy development. This includes arrangements with the FNHA to provide funding for additional clients who became eligible following the transfer of responsibilities in 2013, due to changes in federal legislation, as well as contribution agreements with Indigenous partner organizations, such as the Assembly of First Nations and Inuit Tapiriit Kanatami, and regional Indigenous organizations. Headquarters expenditures account for 1.4% ($32.3 million) of total NIHB expenditures and do not include the $93.0 million in administration (HQ) costs outlined in section 11.

Table 3.2: NIHB expenditures by benefit and region
Region Medical Transportation Pharmacy MS&E Dental Vision Care Mental Health Counselling Other Total
Atlantic $17,848 $55,701 $5,721 $16,003 $3,929 $8,966 $5,319 $113,488
Quebec $32,649 $75,758 $4,275 $26,352 $4,056 $8,613 $2,169 $153,872
Ontario $185,502 $131,045 $13,358 $82,516 $9,804 $31,210 $556 $453,992
Manitoba $304,285 $140,287 $17,418 $78,577 $8,270 $23,533 $802 $573,171
Saskatchewan $137,570 $148,399 $20,830 $86,957 $12,077 $35,304 $6,219 $447,356
Alberta $79,500 $110,449 $13,965 $82,829 $9,153 $20,344 $503 $316,744
North $122,868 $40,397 $8,443 $48,198 $5,067 $4,595 $508 $230,077
Headquarters $0 $0 $0 $0 $0 $0 $32,335 $32,335
Total $880,222 $708,069 $84,011 $425,024 $52,356 $132,565 $48,411 $2,330,658
Source: FST adapted by Program Analytics and Risk Mitigation

NIHB annual expenditures ($ Hundred Thousands) and percentage change

In 2024-2025, NIHB program expenditures totalled $2,330.7 million, an increase of 11.1% from $2,098.2 million in 2023-2024. Since 2015-2016, total expenditures have grown by 111.8%. The annualized rate of growth over this period was 8.5%. There has been wide variation in growth rates between 2015-2016 and 2024-2025, from a low of -1.9% in 2020-2021 to a high of 13.7% in 2021-2022.

Fluctuations in NIHB expenditures growth rates are impacted by a number of factors. Changes in the eligible client population have a direct impact on growth, including an increase in eligible clients as a result of amendments to the Indian Act. The coronavirus (COVID-19) outbreak and provincial and territorial public health restrictions on the provision of in-person services in fiscal year 2020-2021, along with larger than typical utilization of NIHB benefits in fiscal 2021-2022 once restrictions were ended, impacted growth in those years.

Chart 3.2: NIHB annual expenditures ($ Hundred Thousands) and percentage change

Source: FIRMS and FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 3.2: NIHB annual expenditures ($ hundred thousands) and percentage change

This image is a bar graph which visually describes NIHB annual expenditures in millions and annual percentage change by fiscal year, as follows:

  • 2015 to 2016 is $1,101 and 6.7%
  • 2016 to 2017 is $1,207 and 9.7%
  • 2017 to 2018 is $1,309 and 8.4%
  • 2018 to 2019 is $1,391 and 6.2%
  • 2019 to 2020 is $1,519 and 9.3%
  • 2020 to 2021 is $1,491 and -1.9%
  • 2021 to 2022 is $1,695 and 13.7%
  • 2022 to 2023 is $1,892 and 11.6%
  • 2023 to 2024 is $2,098 and 10.9%
  • 2024 to 2025 is $2,330 and 11.1%

NIHB annual expenditures by benefit (Hundred thousands of dollars)

In the 10-year period ending 2024-2025, expenditures for NIHB mental health services grew faster than other benefit areas. Mental health expenditures counselling had the highest percentage growth at 718.8%, from $16.2 million in 2015-2016 to $132.6 million in 2024-2025. Medical transportation had the biggest increase in expenditures from $375.9 million in 2015-2016 to $880.2 million in 2024-2025, a change of 134.2%.

Over the same period, medical supplies and equipment (MS&E) expenditures increased by 174.0% and dental expenditures increased by 98.4%.

Table 3.3: NIHB annual expenditures by benefit (Hundred thousands of dollars)
Benefit 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Medical transportation $375,921 $417,035 $459,505 $495,034 $537,179 $525,719 $602,208 $710,614 $789,621 $880,222
Pharmacy $409,227 $441,186 $467,094 $471,641 $510,691 $536,680 $566,082 $605,837 $648,600 $708,069
MS&E $30,657 $37,031 $40,167 $46,481 $53,222 $50,932 $60,050 $65,181 $75,131 $84,011
Dental $214,189 $232,954 $246,222 $264,015 $277,547 $233,224 $299,075 $329,123 $379,940 $425,024
Vision care $30,016 $32,370 $33,578 $36,467 $45,968 $39,594 $47,609 $49,246 $52,038 $52,356
Mental health counselling $16,191 $21,728 $33,066 $42,656 $55,126 $73,652 $93,686 $98,585 $117,425 $132,565
Other $24,311 $25,172 $29,609 $34,270 $39,751 $30,814 $26,586 $33,157 $35,462 $48,411
Total $1,100,512 $1,207,458 $1,309,240 $1,390,563 $1,519,483 $1,490,615 $1,695,295 $1,891,743 $2,098,218 $2,330,658
Annual % change 6.8% 9.7% 8.4% 6.2% 9.3% -1.9% 13.7% 11.6% 10.9% 11.1%
Source: FIRMS and FST adapted by Program Analytics and Risk Mitigation

Per capita NIHB expenditures by region 2024-2025

Expenditures per capita are total NIHB expenditures divided by the number of eligible clients, regardless of whether clients submitted a claim in the reporting period.

National per capita expenditures for all benefits in 2024-2025 were $2,337. Manitoba had the highest per capita cost at $3,279. The Northern region followed with a per capita cost of $3,030. The higher than average per capita cost for these regions is partly attributable to high medical transportation costs due to the large number of First Nations and Inuit clients living in remote or fly-in only northern communities. By contrast, the Atlantic region had the lowest per capita cost of $1,575, due to the comparatively low medical transportation expenditures in the region.

Chart 3.3: Per capita NIHB expenditures by region

Source: FST and SVS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 3.3: Per capita NIHB expenditures by region

This bar graph visually describes NIHB annual expenditures in millions by fiscal year and by region. Per capita expenditures:

  • for Atlantic are $1,575
  • for Quebec are $1,719
  • for Ontario are $1,899
  • for Manitoba are $3,279
  • for Saskatchewan are $2,549
  • for Alberta are $2,307
  • for the North are $3,030
  • national per capita expenditures are $2,337

4. NIHB pharmacy

The NIHB program covers a comprehensive range of prescription drugs and select over-the-counter medications listed on the NIHB Drug Benefit List (DBL). Pharmacy benefits are evidence based and eligible prescription and over-the-counter medications are covered in accordance with program policies as set out in the NIHB Pharmacy Benefits Guide.

In 2024-2025, the NIHB program paid for pharmacy claims made by 601,045 First Nations and Inuit clients. The total spent for these claims was $708.1 million or 30.4% of total NIHB expenditures. Of all the NIHB program benefits, the pharmacy benefit accounts for the second largest share of expenditures and is the benefit most utilized by clients.

Distribution of NIHB pharmacy expenditures ($ Hundred thousands) 2024-2025

The NIHB pharmacy benefit has multiple parts. Prescription drugs paid through the Health Information and Claims Processing Services (HICPS) system was the largest piece, accounting for $554.5 million or 78.3% of all NIHB pharmacy expenditures, followed by over-the-counter (OTC) and controlled access (CAD) drugs (HICPS) which totalled $137.4 million or 19.4%.

Pharmacy benefit expenditures outside of HICPS, at $2.1 million or 0.3% of pharmacy benefit costs, refers to prescription drugs and OTC medications paid through Indigenous Services Canada regional offices.

Contribution agreements, which accounted for $14.2 million or 2.0% of total pharmacy benefit costs, are used to fund pharmacy benefits through agreements such as those with the Mohawk Council of Akwesasne in Ontario and the Bigstone Cree Nation in Alberta.

Chart 4.1: Distribution of NIHB pharmacy expenditures ($ Hundred thousands)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 4.1: Distribution of NIHB pharmacy expenditures ($ Hundred thousands)

This image is a pie chart which visually describes NIHB pharmacy expenditures in millions and proportion of total expenditures by component type:

  • HICPS pharmacy expenditures are $691.8 million and 97.7%
  • contribution agreements are $14.2 million and 2.0%
  • Non-HICPS benefits expenditures are $2.1 million and 0.3%
  • total expenditures $708.1

Total NIHB pharmacy expenditures by type and region (Hundred thousands of dollars) 2024-2025

Prescription drug costs paid through the HICPS system represented the largest component of total NIHB Pharmacy costs accounting for $554.5 million. Saskatchewan had the largest proportion of these costs at 20.6%, followed by Manitoba at 19.9% and Ontario at 18.7%.

The next highest component was over-the-counter (OTC) and controlled access drug (CAD) costs at $137.4 million or 19.4%. Saskatchewan (23.6%), Manitoba (21.9%) and Alberta (16.1%) had the largest proportions of these costs in 2024-2025.

Table 4.1: Total NIHB pharmacy expenditures by type and region (Hundred thousands of dollars)
Region Operating Total Operating Costs Total Contribution Costs Total Costs
Prescription Drugs OTC/CAD Drugs Drugs Regional
Atlantic $45,341 $10,361 $0 $55,701 $0 $55,701
Quebec $62,296 $13,462 $0 $75,758 $0 $75,758
Ontario $103,673 $21,584 $0 $125,257 $5,788 $131,045
Manitoba $110,196 $30,091 $0 $140,287 $0 $140,287
Saskatchewan $114,284 $32,456 $1,585 $148,324 $75 $148,399
Alberta $80,023 $22,165 $0 $102,187 $8,262 $110,449
North $33,451 $6,431 $476 $40,358 $39 $40,397
Total $554,482 $137,361 $2,061 $693,905 $14,164 $708,069
Source: FST adapted by Program Analytics and Risk Mitigation

Annual NIHB pharmacy expenditures

NIHB pharmacy expenditures increased by 9.2% during fiscal year 2024-2025. Over the past 5 years, growth in pharmacy expenditures ranged from a high of 9.2% this year to a low of 5.1% in 2020-2021.

The 5 year annualized growth rate for NIHB pharmacy expenditures is 6.8%. The introduction of lower cost generic drugs as they become available on the market has kept pharmacy benefit growth moderate. As well, NIHB has negotiated Product Listing Agreements (PLA) with drug manufacturers to allow for the coverage of certain medications at a reduced price through the use of rebates. On March 31, 2025, NIHB had over 350 PLA in effect.

Chart 4.2: Annual NIHB pharmacy expenditures and percentage change

Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 4.2: Annual NIHB pharmacy expenditures and percentage change

This image is a bar graph which visually describes NIHB annual pharmacy expenditures in millions and percentage change by fiscal year, as follows:

  • 2020 to 2021 expenditures are $536.7 million and growth is 5.1%
  • 2021 to 2022 expenditures are $566.1 million and growth is 5.5%
  • 2022 to 2023 expenditures are $605.8 million and growth is 7.0%
  • 2023 to 2024 expenditures are $648.6 million and growth is 7.1%
  • 2024 to 2025 expenditures are $708.1 million and growth is 9.2%
Table 4.2: NIHB pharmacy expenditures ($ Hundred thousands's) by region
Region 2020 to 2021 2021 to 2022 2022 to 2023 2023 to 2024 2024 to 2025
Atlantic $37,323 $40,657 $45,819 $49,470 $55,701
Quebec $53,282 $58,827 $64,799 $70,023 $75,758
Ontario $105,300 $112,069 $113,842 $119,964 $131,045
Manitoba $106,851 $112,353 $120,207 $128,221 $140,287
Saskatchewan $116,188 $120,000 $126,676 $137,470 $148,399
Alberta $84,920 $86,680 $96,511 $102,556 $110,449
North $29,479 $31,499 $33,457 $35,869 $40,397
Total $536,681 $566,082 $605,837 $648,600 $708,069
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

NIHB pharmacy utilization rates by region

Utilization rates represent the number of clients who received at least 1 pharmacy benefit paid through the HICPS system in the fiscal year, as a proportion of the total number of eligible clients.

In 2024-2025, the national utilization rate was 63% for NIHB pharmacy benefits paid through the HICPS system. The rate understates the actual level of utilization as the data do not include pharmacy services provided through contribution agreements and benefits provided through community health facilities or regional offices.

Clients of the Bigstone Cree Nation in Alberta and Akwesasne in Ontario are not included in this calculation as those clients receive pharmacy benefits through a contribution agreement and not through HICPS.

Table 4.3: NIHB pharmacy utilization rates by region
Region Pharmacy Utilization
2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic 60% 61% 63% 64% 65%
Quebec 58% 59% 61% 63% 64%
Ontario 51% 52% 53% 54% 54%
Manitoba 62% 65% 67% 67% 67%
Saskatchewan 63% 65% 68% 68% 69%
Alberta 64% 65% 68% 71% 70%
North 50% 50% 52% 53% 53%
National 58% 59% 61% 62% 63%
Source: HICPS and SVS adapted by Program Analytics and Risk Mitigation

NIHB pharmacy claimants by age group and gender 2024-2025

Of the 983,461 clients eligible to receive benefits under the NIHB program, a total of 601,045 claimants received at least 1 pharmacy item paid through the Health Information and Claims Processing Services (HICPS) system in 2024 to 2025. Of this total, 339,448 were female (56.5%) and 261,597 were male (43.5%). This compares to the total eligible population where 50.7% were female and 49.3% were male.

The average age of pharmacy claimants was 38. The average age for female and male claimants was 38 and 37, respectively.

Pharmacy benefit utilization varies by age. In 2024 to 2025, 3.7% of all clients were in the 0 to 4 age group, but this group accounted for only 0.5% of all pharmacy claims made and only 0.7% of total pharmacy expenditures. In contrast, 10.9% of all eligible clients were in the 65+ age group, but accounted for 25.9% of all pharmacy claims submitted and 17.7% of total pharmacy expenditures.

Chart 4.3: Distribution of eligible NIHB population, pharmacy expenditures and pharmacy incidence by age group

Source: HICPS, FST and SVS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 4.3: Distribution of eligible NIHB population, pharmacy expenditures and pharmacy incidence by age group

This image is a bar graph which visually describes percentage of NIHB annual pharmacy expenditures and incidence by age group, as follows:

Age Eligible clients Expenditures Incidence
0 to 4 3.7% 0.7% 0.5%
5 to 9 6.8% 1.6% 1.0%
10 to 14 8.4% 2.0% 1.3%
15 to 19 9.2% 3.1% 2.1%
20 to 24 8.4% 3.9% 2.8%
25 to 29 8.4% 6.1% 4.6%
30 to 34 8.6% 8.3% 7.1%
35 to 39 7.5% 8.8% 7.9%
40 to 44 6.4% 8.9% 8.3%
45 to 49 5.7% 8.7% 8.3%
50 to 54 5.5% 9.6% 9.4%
55 to 59 5.4% 10.3% 10.4%
60 to 64 5.0% 10.2% 10.7%
65 plus 10.9% 17.7% 25.9%
Total 100.0% 100.0% 100.0%

During 2024-2025, the average claimant aged 65 or more submitted 92 claims compared to 73 claims for their counterpart in the 60 to 64 age group and 6 claims for the average claimant in the 0 to 9 age group.

Pharmacy benefit cost per NIHB claimant expenditures vary according to age. For example, in 2024-2025 the average cost per child aged 0 to 4 years was $285. The cost increased steadily for every age group, with claimants aged 30 to 34 having an average cost of $1,113, comparable to the total average claimant cost of $1,178. Claimants aged 60 to 64 years had the highest cost per claimant with an average of $2,027 for all pharmacy claims received throughout the fiscal year.

NIHB Top ten therapeutic classes by number of claimants 2024-2025

Table 4.5 ranks the top 10 therapeutic classes of prescription drugs according to number of claimants. In 2024-2025, Penicillins had the highest number of distinct claimants, at 181,721. Antidepressants ranked second in number of claimants, with 132,336 followed by Proton Pump Inhibitors with 120,214 claimants.

Table 4.5: NIHB top 10 therapeutic classes by number of claimants
Therapeutic Classification Claimants Percentage change from 2023 to 2024 Examples of product in the therapeutic class
Penicillins 181,721 6.8% Amoxil (Amoxicillin)
Antidepressants 132,336 4.8% Effexor (Venlafaxine)
Proton Pump Inhibitors 120,214 11.0% Losec (Omeprazole)
Non-Steroidal Anti-Inflammatory Drugs (NSAID) 119,526 4.2% Voltaren (Diclofenac)
Beta-Adrenergic Agonists 104,800 9.1% Ventolin (Salbutamol)
HMG-COA Reductase Inhibitors (Statins) 92,696 6.2% Lipitor (Atorvastatin)
Opioid Agonists 92,318 1.9% Statex (Morphine Sulphate)
Adrenals 88,965 8.8% Flovent (Fluticasone Propionate)
Cephalosporins 79,924 3.5% Keflex (Cephalexin)
Angiotensin-Converting Enzyme Inhibitors 74,197 1.5% Altace (Ramipril)
Source: HICPS adapted by Program Analytics and Risk Mitigation

NIHB over-the-counter, including CAD drug claims incidence by therapeutic class 2024-2025

Table 4.6 looks at the number of claims by therapeutic classification for over-the-counter (OTC) drugs.

Vitamins accounted for the largest number of OTC drug claims in 2024-2025 at 1.6 million paid claims or 28.3% of all OTC claims. Central nervous systems agents had the next highest share of OTC claims at 1.1 million (19.9%) followed by electrolytic, caloric and water balance drugs at 481,632 claims (8.8%).

Table 4.6: NIHB OTC, including CAD drug claims incidence by therapeutic class
Category Claims Percentage change from 2023-2024 Examples
Vitamins 1,544,068 -7.5% Vitamin D (Cholecalciferol)
Central Nervous System Agents 1,086,492 1.6% Tylenol (Acetaminophen)
Electrolytic/Caloric/Water Balance 481,632 300.2% Pedialyte (oral electrolyte solution)
Blood Formation and Coagulation 429,378 12.6% Iron (Ferrous Gluconate)
Gastrointestinal Drugs 426,440 9.2% Senokot (Sennosides)
Diabetic Devices 367,847 17.5% Lancets
Skin & Mucous Membrane Agents 268,386 19.5% Nix (Permethrin)
Hormone & Synthetic Substitutes 221,575 4.0% Lantus (Insulin Glargine)
Antihistamines 154,066 7.8% Reactine (Cetirizine)
Autonomic Drugs 122,043 18.5% Nicoderm (Nicotine)
Source: HICPS adapted by Program Analytics and Risk Mitigation

5. NIHB medical supplies and equipment (MS&E)

A range of medical supplies and equipment (MS&E) items are covered by the NIHB program. Items covered through the MS&E benefit are intended to address NIHB clients' medical needs in relation to basic activities of daily living (ADL) such as eating, bathing, dressing, toileting and transferring. MS&E benefits are covered for use at the client's place of primary residence and include:

MS&E benefits are evidence-based and covered in accordance with program policies as set out in the NIHB MS&E Benefits Guide. Some items must be reviewed by the corresponding NIHB regional office before they are distributed by an NIHB provider.

Prior to the 2020-2021 NIHB Annual Report, expenditure and utilization data for the MS&E benefit were combined with pharmacy benefits in reporting.

In 2024-2025, NIHB paid for MS&E claims made by a total of 86,247 First Nations and Inuit clients. The total spent for these claims was $84.0 million or 3.6% of NIHB expenditures.

Distribution of NIHB MS&E expenditures ($ Hundred thousands) 2024-2025

The NIHB MS&E benefit has multiple components. The cost of medical equipment paid through the HICPS system was the largest component, accounting for $58.3 million or 69.4% of all NIHB MS&E expenditures, followed by medical supplies paid through HICPS which totalled $23.9 million or 28.4%.

Contribution agreements, which accounted for $0.8 million or 1.0% of total MS&E benefit costs, are used to fund benefits through agreements such as those with the Mohawk Council of Akwesasne in Ontario and the Bigstone Cree Nation in Alberta.

MS&E benefit costs outside of HICPS, which refers to MS&E items paid through Indigenous Services Canada regional offices, accounted for $1.0 million or 1.2%.

Chart 5.1: Distribution of NIHB MS&E expenditures ($ Millions)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 5.1: Distribution of NIHB MS&E expenditures ($ Millions)

This image is a pie chart which visually describes NIHB medical supplies and equipment expenditures in millions and proportion of total expenditures by component type:

  • HICPS MS&E are $82.2 and 97.8%
  • contribution agreements are $0.8 and 1.0%
  • MS&E benefit costs outside of HICPS are $1.0 and 1.2%
  • total expenditures $84.0

Total NIHB MS&E expenditures by type and region (Hundred Thousands) 2024-2025

Medical equipment costs paid through the HICPS system represented the largest component of total NIHB MS&E expenditures at $58.3 million. Saskatchewan had the largest proportion of these costs at 24.2%, followed by Manitoba at 22.0% and Alberta at 17.3%.

The next highest component was medical supplies costs at $23.9 million. Saskatchewan (28.0%), Ontario (17.8%) and Manitoba (17.0%) had the largest proportions of these costs in 2024 to 2025.

All other MS&E expenditures, including contribution agreement costs, account for only 2.0% of total MS&E expenditure.

Table 5.1: Total NIHB MS&E expenditures by type and region (Hundred thousands of dollars)
Region Operating Total Operating Costs Total Contribution Costs Total Costs
Prescription Drugs OTC/CAD Drugs Drugs Regional
Atlantic $1,386 $4,334 $1 $5,721 $0 $5,721
Quebec $1,304 $2,972 $0 $4,275 $0 $4,275
Ontario $4,243 $8,138 $382 $12,762 $596 $13,358
Manitoba $4,057 $12,834 $526 $17,418 $0 $17,418
Saskatchewan $6,673 $14,122 $36 $20,830 $0 $20,830
Alberta $3,886 $10,074 $5 $13,965 $0 $13,965
North $2,314 $5,867 $42 $8,223 $220 $8,443
Total $23,863 $58,341 $992 $83,196 $816 $84,011
Source: FST adapted by Program Analytics and Risk Mitigation

Annual NIHB MS&E expenditures

NIHB MS&E expenditures increased by 11.8% during fiscal year 2024-2025. Over the past 5 years, growth in MS&E expenditures has ranged from a high of 17.9% in 2021-2022 to a low of -4.3% in 2020-2021.

The 5 year annualized growth rate for NIHB MS&E expenditures is 9.6%.

Chart 5.2: Annual NIHB MS&E expenditures

Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 5.2: Annual NIHB MS&E expenditures

This is a bar graph which visually describes NIHB annual pharmacy expenditures in millions and percentage change by fiscal year, as follows:

This is a bar graph which visually describes NIHB annual pharmacy expenditures in millions and percentage change by fiscal year, as follows:

  • 2020 to 2021 is $50.9 and -4.3%
  • 2021 to 2022 is $60.1 and 17.9%
  • 2022 to 2023 is $65.2 and 8.3%
  • 2023 to 2024 is $75.1 and 15.3%
  • 2024 to 2025 is $84.0 and 11.8%
Table 5.2: Annual MS&E expenditures by region (Hundred Thousands of dollars)
Region 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic $4,177 $4,508 $4,785 $5,473 $5,721
Quebec $2,379 $2,855 $3,149 $3,828 $4,275
Ontario $7,297 $8,701 $10,045 $12,071 $13,358
Manitoba $11,146 $13,330 $13,870 $15,661 $17,418
Saskatchewan $11,908 $13,352 $15,310 $17,587 $20,830
Alberta $9,647 $11,658 $12,503 $13,614 $13,965
North $4,024 $5,647 $5,520 $6,898 $8,443
Total $50,933 $60,050 $65,181 $75,131 $84,011
Source: FST adapted by Program Analytics and Risk Mitigation

NIHB MS&E utilization rates by region

Utilization rates are the number of clients who received at least 1 MS&E benefit paid through the HICPS system in the fiscal year, as a proportion of the total number of eligible clients.

In 2024-2025, the national utilization rate for NIHB MS&E benefits paid through the HICPS system was 9%. The rate understates the actual level of utilization as the data do not include MS&E services provided through contribution agreements and benefits provided through community health facilities.

Clients of the Bigstone Cree Nation in Alberta and Akwesasne in Ontario are not included in this calculation as those clients receive MS&E benefits through a contribution agreement and not HICPS.

Table 5.3: NIHB MS&E utilization rates by region
Region MS&E utilization
2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic 10% 12% 10% 10% 10%
Quebec 7% 9% 7% 7% 8%
Ontario 5% 7% 6% 6% 6%
Manitoba 12% 14% 11% 11% 12%
Saskatchewan 10% 13% 10% 11% 11%
Alberta 8% 10% 8% 8% 9%
North 8% 11% 8% 8% 9%
National 8% 11% 8% 8% 9%
Source: HICPS and SVS adapted by Program Analytics and Risk Mitigation

NIHB MS&E claimants by age group and gender 2024-2025

Of the 983,461 clients eligible to receive benefits under the NIHB program, a total of 86,247 claimants, representing 9% of the NIHB client population, received at least 1 MS&E item paid through the Health Information and Claims Processing Services (HICPS) system in 2024-2025. Of this total, 49,594 were female (57.5%) and 36,653 were male (42.5%). This compares to the total eligible population where 51% were female and 49% were male.

The average age of MS&E claimants was 50. The average age for female and male claimants was 51 and 49, respectively.

Chart 5.3: Distribution of eligible NIHB population, MS&E expenditures and MS&E incidence by age group

Source: HICPS, FST and SVS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 5.3: Distribution of eligible NIHB population, MS&E expenditures and MS&E incidence by age group

This image is a bar graph which visually describes NIHB annual MS&E expenditures and incidence by age group, as follows:

Age Eligible Clients Expenditures Incidence
0 to 4 3.7% 2.2% 1.5%
5 to 9 6.8% 3.8% 3.2%
10 to 14 8.4% 3.2% 2.7%
15 to 19 9.2% 2.8% 2.6%
20 to 24 8.4% 2.3% 2.7%
25 to 29 8.4% 2.8% 3.4%
30 to 34 8.6% 3.6% 4.5%
35 to 39 7.5% 4.3% 5.2%
40 to 44 6.4% 4.9% 5.2%
45 to 49 5.7% 5.3% 6.0%
50 to 54 5.5% 7.5% 7.6%
55 to 59 5.4% 9.4% 9.6%
60 to 64 5.0% 11.2% 10.7%
65 plus 10.9% 36.7% 35.2%
Total 100.0% 100.0% 100.0%

MS&E benefit utilization varies by age. In 2024-2025, 3.7% of all clients were in the 0 to 4 age group, but this group accounted for only 1.5% of all MS&E claims made and only 2.2% of total MS&E expenditures. In contrast, 10.9% of all eligible clients were in the 65+ age group, but they accounted for 35.2% of all MS&E claims submitted and 36.7% of total MS&E expenditures.

The average MS&E claimant submitted 5 claims in 2024-2025, a rate that is relatively consistent over all age groups.

NIHB medical supplies expenditures by category 2024-2025

In 2024-2025, medical surgical supplies such as incontinence items accounted for 80.3% of all medical supply expenditures, an increase from the 78.5% recorded in 2023-2024. Self-care supplies, such as enteral feeding bags, represented 6.3% of all medical supply expenditures, followed by prosthetic supplies, such as prosthetic liners at 4.1%.

Chart 5.4: NIHB medical supplies expenditures by category

Source: HICPS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 5.4: NIHB medical supplies expenditures by category

This bar graph visually describes percentage of NIHB medical equipment expenditures by category, as follows:

  • medical surgical supplies is 80.3%
  • self-care supplies is 6.3%
  • prosthetic supplies is 4.1%
  • audiology supplies is 3.2%
  • oxygen supplies is 2.2%
  • respiratory supplies is 2.0%
  • all others is 1.8%

NIHB medical equipment expenditures by category 2024-2025

In 2024-2025, mobility equipment such as wheelchairs accounted for 19.0% of all medical equipment expenditures, a decrease from the 21.7% recorded in 2023-2024. Audiology equipment, such as hearing aids, represented 18.3% of all medical equipment expenditures, followed by respiratory equipment such as CPAP machines at 11.8%.

Chart 5.5: NIHB medical supplies expenditures by category.

Source: HICPS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 5.5: NIHB medical supplies expenditures by category

This bar graph visually describes percentage of NIHB medical equipment expenditures by category, as follows:

  • mobility equipment is 19.0%
  • audiology equipment is 18.3%
  • self-care equipment is 11.8%
  • respiratory equipment is 9.6%
  • oxygen equipment is 7.7%
  • orthotics equipment is 7.0%
  • all others is 14.7%

6. NIHB dental

The NIHB program covers a broad range of dental services, including:

Dental benefits are covered in accordance with program policies as set out in the NIHB Dental Benefits Guide.

In 2024-2025, a total of 359,138 First Nations and Inuit clients accessed dental benefits through the NIHB program, based on claims paid through the HICPS system. The total expenditure for dental benefits was $425.0 million or 18.2% of total NIHB expenditures. The dental benefit accounts for the third largest program expenditure.

Some dental services require predetermination prior to the initiation of treatment. Predetermination is a review that determines if the proposed dental service is covered under the program's guidelines and criteria, as described in the guide. This review is undertaken by the Dental Predetermination Centre (DPC).

Distribution of NIHB dental expenditures ($ millions) 2024-2025

NIHB dental expenditures include multiple components. Dental costs paid through the HICPS system represented the largest expenditure portion, accounting for $399.2 million or 93.3% of all NIHB dental costs.

The next highest component was contribution agreements, which accounted for $16.1 million or 3.8% of total dental expenditures. Contribution agreements are used to fund dental benefits through agreements such as those with the Mohawk Council of Akwesasne in Ontario and the Bigstone Cree Nation in Alberta.

Dental benefit expenditures outside of HICPS, which are comprised mostly of contract dentists providing services to clients in remote communities, totalled $9.7 million or 2.3% of total costs.

Chart 6.1: Distribution of NIHB dental expenditures ($ millions)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 6.1: Distribution of NIHB dental expenditures ($ millions)

This image is a pie chart which visually describes NIHB dental expenditures in millions by component type.

  • HICPS dental expenditures are $399.2 and 93.9%
  • Dental benefit costs outside of HICPS are $9.7 and 2.3%
  • contribution agreements are $16.1 and 3.8%
  • total dental expenditures are $425.0

Total NIHB dental expenditures by type and region (Hundred Thousands of dollars) 2024-2025

Of the $425.0 million in NIHB dental expenditures in 2024-2025, Saskatchewan (20.5%), Alberta (19.5%) and Ontario (19.4%) had the largest overall proportion. Saskatchewan had the highest total dental expenditures at $87.0 million and the Atlantic region had the lowest total dental expenditures at $16.0 million.

Table 6.1: Total NIHB dental expenditures by type and region (Hundred Thousands of dollars)
Region Operating costs Total operating costs Total contribution costs Total costs
Fee-for-service Contract dentists
Atlantic $15,965 $37 $16,003 $0 $16,003
Quebec $26,352 $0 $26,352 $0 $26,352
Ontario $72,260 $2,904 $75,165 $7,352 $82,516
Manitoba $71,284 $6,414 $77,698 $879 $78,577
Saskatchewan $82,651 $0 $82,651 $4,306 $86,957
Alberta $79,467 $0 $79,467 $3,363 $82,829
North $47,658 $348 $48,005 $193 $48,198
Total $399,228 $9,704 $408,932 $16,093 $425,024
Source: FST adapted by Program Analytics and Risk Mitigation

Annual NIHB dental expenditures

NIHB dental expenditures increased by 11.9% during fiscal year 2024-2025. Over the last 5 years, annual growth rates for NIHB dental expenditures have ranged from a high of 28.2% in 2021-2022 to a low of -16.0% in 2020-2021.

The coronavirus (COVID-19) outbreak and provincial and territorial public health restrictions on the provision of in-person services in fiscal year 2020 to 2021, along with larger than typical utilization of the benefit in fiscal 2021-2022 once restrictions were ended, significantly impacted growth in those 2 years.

The 5 year annualized growth rate for NIHB dental expenditures is 8.9%.

Chart 6.2: NIHB dental expenditures and annual percentage change

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 6.2: NIHB dental expenditures and annual percentage change

This image is a bar graph which visually describes NIHB dental expenditures in millions and annual percentage change by fiscal year, as follows:

  • 2020 to 2021 is $233.2 and -16.0%
  • 2021 to 2022 is $299.1 and 28.2%
  • 2022 to 2023 is $329.1 and 10.0%
  • 2023 to 2024 is $379.9 and 15.4%
  • 2024 to 2025 is $425.0 and 11.9%

NIHB dental expenditures by region

Table 6.2: NIHB dental expenditures by region (Hundred Thousands of dollars)
Region MS&E utilization
2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic $9,455 $11,801 $12,638 $14,425 $16,003
Quebec $14,934 $19,092 $20,427 $23,367 $26,352
Ontario $49,251 $59,326 $67,128 $78,995 $82,516
Manitoba $49,414 $57,381 $60,247 $68,952 $78,577
Saskatchewan $47,507 $63,408 $70,480 $78,046 $86,957
Alberta $47,799 $58,790 $65,240 $74,484 $82,829
North $20,703 $26,830 $30,332 $38,600 $48,198
Total $233,224 $299,075 $329,123 $379,940 $425,024
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

NIHB dental utilization rates by region

Utilization rates reflect the number of clients who, during the fiscal year, received at least 1 dental service paid through the HICPS system as a proportion of the total number of eligible clients.

In 2024-2025, the national utilization rate for dental benefits paid through the HICPS system was 37%. NIHB dental utilization rates in 2020-2021 were impacted by provincial and territorial public health restrictions on the provision of in-person services due to the coronavirus (COVID-19) outbreak.

The rates understate the actual level of utilization as the data do not include dental services provided through community health facilities or other Indigenous Services Canada programs such as Community Oral Health Services which include dental therapy services and the Children's Oral Health Initiative (COHI). Clients of the Bigstone Cree Nation in Alberta and Akwesasne in Ontario are not included in this calculation as those clients receive dental benefits through a contribution agreement and not through HICPS.

Over the 2 year period between 2023-2024 and 2024-2025, 477,993 distinct clients received NIHB dental services through HICPS, resulting in an overall 50% utilization rate over this time.

Table 6.3: NIHB dental utilization rates by region
Region Dental utilization NIHB dental
utilization
last two years 2023 to 2025
2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic 30% 35% 35% 36% 37% 48%
Quebec 34% 38% 39% 39% 39% 50%
Ontario 28% 32% 34% 35% 34% 45%
Manitoba 27% 32% 33% 34% 34% 47%
Saskatchewan 32% 37% 38% 38% 39% 53%
Alberta 38% 43% 44% 44% 46% 60%
North 29% 33% 35% 35% 37% 52%
National 30% 35% 36% 37% 37% 50%
Source: HICPS and SVS adapted by Program Analytics and Risk Mitigation

NIHB dental claimants by age group, gender and region 2024-2025

Of the 983,461 clients eligible to receive dental benefits through the NIHB program, 359,138 claimants (37%) received at least 1 dental procedure paid through the HICPS system in 2024-2025.

Of this total, 201,591 were female (56%) and 157,547 were male (44%), compared to the total eligible NIHB population where 51% were female and 49% were male.

The average age of dental claimants was 34, indicating clients tend to access dental services at a slightly younger age compared to pharmacy services at 38 years of age. The average age for female and male claimants was 35 and 32 years of age, respectively.

Chart 6.3: Distribution of eligible NIHB population, dental expenditures and incidence by age group

Source: HICPS and SVS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 6.3: Distribution of eligible NIHB population, dental expenditures and incidence by age group

This image is a bar graph which visually describes distribution percentage of NIHB dental clients, incidence and expenditures by age group, as follows:

Age Eligible clients Expenditures Incidence
0 to 4 3.7% 3.7% 3.7%
5 to 9 6.8% 6.9% 9.4%
10 to14 8.4% 8.9% 11.2%
15 to 19 9.2% 12.3% 11.6%
20 to 24 8.4% 9.6% 8.7%
25 to 29 8.4% 8.7% 8.3%
30 to 34 8.6% 8.5% 8.2%
35 to 39 7.5% 7.4% 7.0%
40 to 44 6.4% 6.0% 5.8%
45 to 49 5.7% 5.3% 5.1%
50 to 54 5.5% 5.1% 4.9%
55 to 59 5.4% 5.2% 4.9%
60 to 64 5.0% 4.6% 4.3%
65 plus 10.9% 7.7% 6.9%
  100.0% 100.0% 100.0%

Approximately 32% of all dental claimants were under the age of 20. 36% of male claimants were in this age group compared to 30% of female claimants. Approximately 9% of all claimants were seniors aged 65 and over in 2024-2025.

NIHB fee-for-service dental expenditures by service category 2024-2025

In 2024-2025, expenditures for restorative services, for example, crowns, fillings, etc. were the highest of all dental service categories at $179.6 million. Diagnostic services, such as examinations, radiographs, etc. at $47.2 million and preventive services, for example, scaling, sealants, etc. at $45.0 million were the next highest service categories. Rounding out the top 5 were oral surgery, including extractions, etc. at $41.7 million and endodontic services, such as root canal treatments, etc. at $30.9 million.

Table 6.4: NIHB fee-for-service dental expenditures by service category
Dental sub-benefit 2023-2024 2024-2025 Percentage change from 2023-2024
Restorative services $161.3 $179.6 11.3%
Diagnostic services $41.7 $47.2 13.2%
Preventive services $38.5 $45.0 16.7%
Oral surgery $37.2 $41.7 12.2%
Endodontic services $28.3 $30.9 9.3%
Source: HICPS adapted by Program Analytics and Risk Mitigation

In 2024-2025, the 3 highest dental procedures by expenditure were composite restorations ($152.4 million), scaling ($30.8 million) and extractions ($30.2 million).

Table 6.5: NIHB fee-for-service dental expenditures by procedure
Dental procedure 2023-2024 2024-2025 Percentage change from 2023-2024
Composite restorations $138.4 $152.4 10.1%
Scaling $27.9 $30.8 10.3%
Extractions $26.6 $30.2 13.4%
Root canal therapy $26.1 $28.3 8.4%
Intraoral radiographs $15.8 $17.8 12.6%
Source: HICPS adapted by Program Analytics and Risk Mitigation

7. NIHB Medical transportation

In 2024-2025, Non-Insured Health Benefits Medical Transportation expenditures were $880.2 million or 37.8% of total NIHB expenditures. The medical transportation benefit is the largest program expenditure.

NIHB medical transportation benefits are intended to assist eligible clients to access medically necessary health services that are not available on reserve or in their community of residence.

Medical transportation benefits are managed by Indigenous Services Canada regional offices, or by First Nations or Inuit Health Authorities, organizations or territorial governments who manage the benefit through contribution agreements.

Medical transportation benefits include:

Medical transportation benefits may be provided for clients to access the following types of medically required health services:

Medical transportation benefits may also be provided for a medical escort, such as a nurse or a non-medical escort, such as a family member or caregiver, to travel with a client who needs assistance or to accompany pregnant clients who require transportation outside their community to deliver their babies.

In addition to client travel, medical transportation expenditures also include costs associated with transporting healthcare professionals to under-serviced or remote and isolated communities to provide services.

Distribution of NIHB medical transportation expenditures ($ millions) 2024-2025

In 2024-2025, NIHB medical transportation expenditures totalled $880.2 million.

Contribution agreements for the management of medical transportation benefits by First Nations communities, territorial governments and other organizations represented the largest component, accounting for $342.4 million, or 38.9% of total benefit expenditures.

Of benefit expenditures managed by the NIHB program, accommodations and meals at $150.2 million (17.1%), scheduled flights at $135.9 million (15.4%) and air ambulance at $123.4 million (14.0%) were the largest expenditures, accounting for a combined total of over 45%.

Rounding out medical transportation expenditures are costs for land ambulance at $69.5 million (7.9%), land and water transportation at $39.8 million (4.5%) and chartered flights at $19.0 million (2.2%).

Chart 7.1: Distribution of NIHB medical transportation expenditures ($ millions)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 7.1: Distribution of NIHB medical transportation expenditures ($ millions)

This image is a pie chart which visually describes NIHB medical transportation expenditures and percentage by type, as follows:

  • expenditures for scheduled flights are $135.9 million and 15.4%
  • accommodations and meals are $150.2 million and 17.1%
  • air ambulances are $123.4 million and 14.0%
  • land ambulances are $69.5 million and 7.9%
  • land and water transportation are $39.8 million and 4.5%
  • chartered flights are $19.0 million and 2.2%
  • contribution agreements are $342.4 million and 38.9%
  • total of $880.2 million

Annual NIHB medical transportation expenditures

NIHB medical transportation expenditures increased by 11.5% in 2024-2025 compared to the previous year. Over the past 5 years, overall medical transportation costs have grown by 67.4% from $525.7 million in 2020-2021 to $880.2 million in 2024-2025.

Chart 7.2: Annual NIHB medical transportation expenditures

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 7.2: Annual NIHB medical transportation expenditures

This image is a bar graph which visually describes NIHB medical transportation expenditures and percentage growth by year, as follows:

  • 2020 to 2021 are $525.7 and -2.1%
  • 2021 to 2022 are $602.2 and 14.6%
  • 2022 to 2023 are $710.6 and 18.0%
  • 2023 to 2024 are $789.6 and 11.1%
  • 2024 to 2025 are $880.2 and 11.5%

On a regional basis, the highest 5 year growth rate was in Ontario where expenditures grew by 104.6% from $90.6 million in 2020-2021 to $185.5 million in 2024-2025. This was followed by Manitoba with an increase of 95.3% from $155.8 million in 2020-2021 to $304.3 million in 2024-2025.

Table 7.1: NIHB Medical transportation expenditures by region (Hundred Thousands of dollars)
Region 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic $13,263 $15,776 $17,512 $18,294 $17,840
Quebec $25,379 $26,775 $28,921 $28,596 $32,649
Ontario $90,646 $114,814 $140,343 $166,036 $185,502
Manitoba $155,790 $184,200 $233,140 $261,374 $304,285
Saskatchewan $84,951 $103,152 $114,863 $115,915 $137,570
Alberta $59,492 $67,206 $71,908 $69,508 $79,500
North $96,194 $90,286 $103,926 $129,898 $122,868
Total $525,715 $602,208 $710,614 $789,621 $880,213
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

NIHB medical transportation expenditures by type and region (Hundred Thousands of dollars) 2024-2025

In 2024-2025 Manitoba had the highest overall NIHB medical transportation expenditures at $304.3 million, primarily as a result of air transportation, which totalled $180.4 million. High medical transportation costs in the region reflect in part the large number of First Nations clients living in remote or fly-in only northern communities.

Ontario had the second highest medical transportation expenditures total in 2024-2025 at $185.5 million. Saskatchewan followed at $137.6 million.

Table 7.2: NIHB medical transportation expenditures by type and region (Hundred Thousands of dollars)
Type Atlantic Quebec Ontario Manitoba Saskatchewan Alberta North Total
Scheduled flights $2,607 $556 $60,736 $63,656 $4,588 $1,103 $2,627 $135,872
Air ambulance $72 $42 $613 $105,683 $10,969 $3,319 $2,700 $123,397
Chartered flights $0 $4 $1,125 $11,073 $3,592 $3,238 $0 $19,033
Land ambulance $493 $236 $1,085 $10,644 $40,137 $16,881 $1 $69,475
Land and water $1,171 $387 $7,372 $5,612 $19,608 $4,496 $1,180 $39,834
Accommodations and meals $1,759 $258 $64,384 $55,531 $14,256 $10,283 $3,723 $150,204
Total operating $6,102 $1,483 $135,314 $252,199 $93,150 $39,321 $10,230 $537,806
Total contributions $11,738 $31,167 $50,187 $52,086 $44,420 $40,180 $112,638 $342,416
Total $17,840 $32,649 $185,502 $304,285 $137,570 $79,500 $122,868 $880,222
Percentage change from 2023-2024 -2.5% 14.2% 11.7% 16.4% 18.7% 14.4% -5.4% 11.5%
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

8. NIHB vision care

The NIHB program provides coverage for vision care benefits as set out in the NIHB Guide to Vision Care Benefits, including:

Some items such as ocular prosthesis and low vision aids are covered by NIHB as medical supplies and equipment benefits.

In 2024-2025, a total of 178,094 First Nations and Inuit clients accessed vision care benefits through the NIHB program, based on claims paid through the HICPS system. The total expenditure for vision care benefits was $52.4 million or 2.2% of total NIHB expenditures.

Distribution of NIHB vision care expenditures ($ millions) 2024-2025

NIHB vision care expenditures are comprised of several distinct components. Fee-for-service vision care costs paid through HICPS system represented the largest expenditure portion, accounting for $47.7 million or 91.2% of all NIHB vision care costs.

The next highest component was contribution agreements, which accounted for $4.6 million or 8.7% of total vision care costs. Contribution agreements are used to fund First Nations or Inuit communities and organizations or territorial governments directly for the provision of vision care benefits.

Regional vision care, at $39,200 or 0.1% of vision care benefit costs, refers to vision care claims paid through Indigenous Services Canada regional offices.

Chart 8.1: Distribution of NIHB vision care expenditures ($ millions)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 8.1: Distribution of NIHB vision care expenditures ($ millions)

This image is a pie chart which visually describes NIHB vision care expenditures and proportion of total expenditure by component type as follows:

  • vision care (HICPS) at $47.7 million and 91.2%%
  • vision care (regional) at $39 thousand and 0.1%
  • contribution agreements at $4.6 million and 8.7%
  • total of $52.4 million

NIHB vision care expenditures and growth by region (Hundred Thousands of dollars) 2024-2025

NIHB vision care expenditures totalled $52.4 million in 2024-2025, an increase of 0.6% from the previous year.

Saskatchewan had the highest vision care costs at $12.0 million or 23.1% of total vision care expenditure, followed by Ontario at $9.8 million (18.7%) and Alberta at $9.2 million (17.5%).

Table 8.1: NIHB vision care expenditures and growth by region (Hundred Thousands of dollars)
Region Operating Total Operating Costs Total Contribution Costs Total Costs
Fee for Service Regional
Atlantic $3,927 $1.7 $3,929 $0 $3,929
Quebec $4,056 $0.0 $4,056 $0 $4,056
Ontario $9,160 $0.0 $9,160 $644 $9,804
Manitoba $7,577 $0.0 $7,577 $693 $8,270
Saskatchewan $12,077 $0.0 $12,077 $0 $12,077
Alberta $7,620 $0.0 $7,620 $1,533 $9,153
North $3,327 $37.6 $3,364 $1,703 $5,067
Total $47,743 $39.2 $47,783 $4,573 $52,356
Source: FST adapted by Program Analytics and Risk Mitigation

Annual NIHB vision care expenditures and percentage change

NIHB vision care expenditures increased by 0.6% during fiscal year 2024-2025. Over the past 5 years, growth in vision care expenditures has ranged from a high of 20.9% in 2021-2022 to a low of -14.4% in 2020-2021.

The 5 year annualized growth rate for NIHB vision care expenditures is 2.6%.

Chart 8.2: Annual NIHB vision care expenditures hundred

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 8.2: Annual NIHB vision care expenditures (Hundred Thousands of dollars)

This image is a bar graph which visually describes NIHB vision care expenditures by year in millions and percentage change, as follows:

  • 2020 to 2021 is $39.4 million and -14.4%
  • 2021 to 2022 is $47.6 million and 20.9%
  • 2022 to 2023 is $49.2 million and 3.4%
  • 2023 to 2024 is $52.0 million and 5.7%
  • 2024 to 2025 is $52.4 million and 0.6%

On a regional basis, the highest growth rate over this 5 year period was in the North where expenditures grew by 58.1% from $3.2 million in 2020-2021 to $5.0 million in 2024-2025. Saskatchewan had largest net increase in expenditures over this period, where costs grew by $3.6 million.

Table 8.2: NIHB vision care expenditures (Hundred Thousands of dollars) by region
Region 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic $3,436 $4,158 $4,149 $3,986 $3,929
Quebec $2,814 $3,938 $4,081 $4,113 $4,056
Ontario $7,346 $8,113 $8,633 $9,732 $9,804
Manitoba $6,042 $7,334 $7,669 $8,605 $8,270
Saskatchewan $8,493 $10,581 $10,585 $11,243 $12,077
Alberta $8,030 $9,405 $9,446 $9,355 $9,153
North $3,206 $4,081 $4,683 $5,004 $5,067
Total $39,367 $47,609 $49,246 $52,038 $52,356
Source: FST adapted by Program Analytics and Risk Mitigation

NIHB vision care claimants by age group, gender and region 2024-2025

Of the 983,461 clients eligible to receive benefits under the NIHB program, a total of 178,094 claimants, representing 18.1% of the NIHB client population, had at least 1 vision care claim paid through the Health Information and Claims Processing Services (HICPS) system in 2024-2025. Of this total, 107,261 were female (60.2%) and 70,833 were male (39.8%). This compares to the total eligible population where 51% were female and 49% were male.

The average age of vision care claimants was 37 years of age. The average age for female and male claimants was 37 and 36 years, respectively.

NIHB vision care utilization rates by region

Utilization rates reflect the number of clients who, during the fiscal year, received at least 1 vision care service paid through the HICPS system as a proportion of the total number of eligible clients.

In 2024-2025, the national utilization rate for vision care benefits paid through the HICPS system was 18%. NIHB vision care utilization rates for 2020-2021 are artificially low as the data for that year are incomplete.

The rates understate the actual level of utilization as the data do not include vision care services provided through contribution agreements and benefits provided through community health facilities or other Indigenous Services Canada.

Over the 2 year period between April 1, 2023 and March 31, 2025, 304,784 distinct clients received NIHB vision care services through HICPS, resulting in an overall 31% utilization rate over this time.

Table 8.3: NIHB vision care utilization
Region Vision utilization NIHB vision care
utilization
last 2 years 2023 to 2025
2020 to 2021 2021 to 2022 2022 to 2023 2023 to 2024 2024 to 2025
Atlantic 18% 22% 22% 21% 21% 36%
Quebec 13% 17% 16% 16% 16% 28%
Ontario 10% 13% 13% 14% 14% 26%
Manitoba 12% 15% 15% 17% 16% 29%
Saskatchewan 18% 24% 24% 25% 26% 42%
Alberta 16% 21% 19% 20% 20% 34%
North 9% 11% 13% 13% 15% 25%
National 13% 17% 17% 18% 18% 31%
Source: HICPS and SVS adapted by Program Analytics and Risk Mitigation

NIHB vision care expenditures by category 2024-2025

In 2024-2025, new eyewear, such as eyeglasses, accounted for $42.1 million or 85.9% of all HICPS vision care expenditures. Eye exams were $6.3 million or 12.9%, followed by repairs at $258 thousand or 0.5%.

Table 8.4: NIHB vision care claimants and expenditures (Hundred Thousands of dollars) by category
Category Claimants Expenditures Percentage change from previous year
New Eyewear 150,807 $42,089,794 3.7%
Eye Exams 84,645 $6,324,707 6.4%
Repairs 2,665 $258,571 -8.2%
Early Replacement 1,440 $242,420 0.2%
Add Ons 8,301 $71,393 -7.4%
Source: HICPS adapted by Program Analytics and Risk Mitigation

9. NIHB mental health counselling

The NIHB program provides coverage for mental health benefits as set out in the NIHB Guide to Mental Health Counselling Services. The NIHB program's mental health counselling benefit is intended to provide coverage for professional mental health counselling to complement other mental wellness services that may be available to clients or in communities. Mental health counselling is eligible for coverage when it is provided by an NIHB recognized mental health professional such as a registered psychologist. The mental health counselling benefit is offered in a way that:

In 2024-2025, a total of 46,700 First Nations and Inuit clients accessed mental health counselling benefits through the NIHB program, based on claims paid through the HICPS system. The total expenditure for mental health counselling benefits was $132.6 million or 5.7% of total NIHB expenditures.

Distribution of NIHB mental health counselling expenditures ($ millions) 2024-2025

NIHB mental health counselling expenditures are comprised of several distinct components. Fee-for-service mental health counselling costs paid through HICPS system represented the largest expenditure portion, accounting for $84.6 million or 63.8% of all NIHB mental health counselling costs.

The next highest component was contribution agreements, which accounted for $29.7 million or 22.4% of total mental health counselling costs. Contribution agreements are used to fund First Nations or Inuit communities and organizations or territorial governments directly for the provision of mental health counselling benefits.

Regional mental health counselling, at $18.3 million or 13.8% of mental health counselling benefit costs, refers to mental health counselling claims paid through Indigenous Services Canada regional offices.

Chart 9.1: Distribution of NIHB mental health counselling expenditures ($ millions)

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 9.1: Distribution of NIHB mental health counselling expenditures ($ millions)

This image is a pie chart which visually describes NIHB mental health counselling expenditures in millions and proportion of total expenditures by component type as follows:

  • mental health counselling (HICPS) at $84.6 and 63.8%
  • mental health counselling outside of HICPS at $18.3 and 13.8%
  • contribution agreements at $29.7 and 22.4%

NIHB mental health counselling expenditures by region (Hundred Thousands of dollars) 2024-2025

NIHB mental health counselling expenditures totalled $132.6 million in 2024-2025, an increase of 12.9% from the previous year.

Saskatchewan had the highest mental health counselling costs at $35.3 million, or 26.6% of total mental health counselling expenditures, followed by Ontario at $31.2 million (23.5%) and Manitoba at $23.5 million (17.8%).

Table 9.1: NIHB mental health counselling expenditures by region (Hundred Thousands of dollars)
Region Operating costs Total operating costs Total contribution costs Total costs
Mental health counselling (HICPS) Mental health counselling (Regional)
Atlantic $5,358 $78 $5,436 $3,531 $8,966
Quebec $5,183 $1,943 $7,126 $1,487 $8,613
Ontario $29,549 $0 $29,549 $1,661 $31,210
Manitoba $9,555 $8,811 $18,366 $5,167 $23,533
Saskatchewan $21,391 $3,307 $24,699 $10,605 $35,304
Alberta $10,898 $4,197 $15,095 $5,249 $20,344
North $2,626 $0 $2,626 $1,969 $4,595
Total $84,559 $18,336 $102,895 $29,670 $132,565
Source: FST adapted by Program Analytics and Risk Mitigation

NIHB mental health counselling expenditures and annual percentage change

NIHB mental health counselling expenditures increased by 12.5% during fiscal year 2024-2025. Over the past 5 years, mental health counselling costs have grown by 80.8% from $73.3 million in 2020-2021 to $132.6 million in 2024-2025. Over the past 5 years, growth in mental health counselling expenditures has ranged from a high of 33.0% in 2020-2021 to a low of 5.2% in 2022-2023.

The 5 year annualized growth rate for NIHB mental health counselling expenditures is 19.2%.

Chart 9.2: NIHB mental health counselling expenditures and annual percentage change

Source: FST adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 9.2: NIHB mental health counselling expenditures and annual percentage change

This image visually describes NIHB mental health counselling expenditures and annual percentage change by year, as follows:

  • 2020 to 2021 is $73.7 million and 33.0%
  • 2021 to 2022 is $93.7 million and 27.8%
  • 2022 to 2023 is $98.6 million and 5.2%
  • 2023 to 2024 is $117.4 million and 19.1%
  • 2024 to 2025 is $132.6 million and 12.9%

On a regional basis, the highest growth rates over this period were in Saskatchewan where expenditures grew by 110.5% from $16.8 million in 2020-2021 to $35.3 million in 2024-2025. This was followed by Ontario with an increase of 101.5% from $15.5 million in 2020-2021 to $31.2 million in 2024-2025.

Table 9.2: NIHB mental health expenditures (Hundred Thousands of dollars)
Region 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic $6,037 $7,001 $6,918 $7,788 $8,966
Quebec $4,493 $5,604 $6,381 $7,404 $8,613
Ontario $15,491 $21,762 $24,491 $27,432 $31,210
Manitoba $13,803 $16,333 $16,393 $20,003 $23,533
Saskatchewan $16,770 $24,881 $25,194 $31,869 $35,304
Alberta $12,843 $14,771 $15,815 $18,216 $20,344
North $3,895 $3,333 $3,394 $4,711 $4,595
Total $73,332 $93,686 $98,585 $117,425 $132,565
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

NIHB mental health counselling claimants by age group, gender and region 2024-2025

In 2024-2025 a total of 46,700 claimants, representing 5.3% of the NIHB client population, had at least 1 mental health counselling claim paid through the Health Information and Claims Processing Services (HICPS) system. Of this total, 32,018 were female (68.6%) and 14,682 were male (31.4%). This compares to the total eligible population where 51% were female and 49% were male.

These figures underrepresent mental health counselling utilization because they do not include clients accessing mental health counselling benefits delivered through contribution agreements or through travelling provider arrangements. Clients in Nunavut and Northwest Territories, where mental health counselling services are funded via contribution agreements, are not included in this calculation.

The average age of mental health counselling claimants was 32 years. The average age for female and male claimants was 33 and 31 years respectively.

NIHB mental health counselling utilization rates by region

Utilization rates reflect the number of clients who, during the fiscal year, received at least 1 mental health counselling service paid through the HICPS system as a proportion of the total number of eligible clients.

In 2024-2025, the national utilization rate for mental health counselling benefits paid through the HICPS system was 5%. NIHB mental health counselling utilization rates in 2020-2021 are artificially low as the data for that year are incomplete.

The rates understate the actual level of utilization as the data do not include mental health counselling services provided through contribution agreements and benefits provided through community health facilities or other Indigenous Services Canada. Note that mental health counselling utilization in the North is unavailable as mental health counselling services for clients in Nunavut and Northwest Territories are funded via contribution agreements.

Table 9.3: NIHB mental health counselling utilization
Region 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Atlantic 2% 3% 3% 3% 4%
Quebec 2% 2% 2% 3% 3%
Ontario 4% 4% 5% 5% 6%
Manitoba 2% 2% 2% 3% 3%
Saskatchewan 3% 4% 5% 6% 7%
Alberta 2% 3% 3% 4% 5%
National 2% 3% 3% 4% 5%
Source: HICPS and SVS adapted by Program Analytics and Risk Mitigation

10. 10-year regional expenditure trends

Atlantic region

Annual expenditures in the Atlantic region for 2024-2025 totalled $113.5 million, an increase of 11.0% over the $102.3 million spent in 2023-2024. Pharmacy expenditures increased by 12.6 to $55.7 million, medical transportation costs decreased by 2.4 to $17.8 million and dental expenditures increased by 10.9% to $16.0 million. Mental health expenditures increased by 15.1%, MS&E expenditures increased by 4.5% and vision care expenditures decreased by 1.4%.

Pharmacy expenditures accounted for almost half of NIHB expenditures in the Atlantic region at 49.1%. Medical transportation expenditures ranked second at 15.7%, followed by dental at 14.1%. MS&E, vision care and mental health counselling expenditures accounted for 5.0%, 7.9% and 4.7% of total expenditures, respectively.

Chart 10.1: Percentage change in Atlantic region NIHB expenditures (Hundred Thousands of dollars)

Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.1: Percentage change in Atlantic region NIHB expenditures (Hundred Thousands of dollars)

This image is a stacked bar graph which visually describes NIHB expenditures and annual percentage change in the Atlantic region, as follows:

Atlantic region 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures ($M) $50,773 $55,079 $60,040 $63,342 $73,071 $73,984 $84,227 $92,488 $102,281 $113,488
Total benefits annual % change 8.2% 8.5% 9.0% 5.5% 15.4% 1.2% 13.8% 9.8% 10.6% 11.0%

Annual expenditures by benefit (Hundred Thousands of dollars)

Table 10.1: Atlantic region annual expenditures by benefit (Hundred Thousands of dollars)
Atlantic region 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $8,380 $9,277 $11,147 $11,820 $13,910 $13,263 $15,776 $17,512 $18,294 $17,848
Pharmacy $27,665 $28 976 $29,741 $30,448 $35,365 $37,323 $40,657 $45,819 $49,470 $55,701
MS&E $2,449 $2,990 $3,279 $3,900 $4,359 $4,177 $4,508 $4,785 $5,473 $5,721
Dental $8,846 $9,593 $10,610 $10,841 $11,545 $9,455 $11,801 $12,638 $14,425 $16,003
Mental health $419 $601 $1,204 $1,932 $3,428 $6,037 $7,001 $6,918 $7,788 $8,966
Vision care $3,021 $3,502 $3,632 $3,885 $4,150 $3,436 $4,158 $4,149 $3,986 $3,929
Other $44 $207 $427 $516 $314 $293 $326 $666 $2,844 $5,319
Total $50,824 $55,146 $60,040 $63,342 $73,071 $73,984 $84,227 $92,488 $102,281 $113,488
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Quebec

Annual expenditures in Quebec for 2024-2025 totalled $153.9 million, an increase of 7.8% from the $138.0 million spent in 2023-2024.

Medical transportation expenditures increased by 14.2% to $32.6 million, pharmacy expenditures increased by 8.2% to $75.8 million and dental expenditures increased by 12.8% to $26.3 million. MS&E costs increased by 11.7%, mental health expenditures increased by 16.3% and vision care expenditures decreased by 1.4%.

Pharmacy expenditures accounted for half of total NIHB expenditures in Quebec in 2024-2025 at 49.2%. Medical transportation expenditures ranked second at 21.2%, followed by dental at 17.1%. Mental health counselling, MS&E and vision care expenditures accounted for 5.6%, 2.8% and 2.6% of total expenditures, respectively.

Chart 10.2: Percentage change in Quebec NIHB expenditures (Hundred Thousands of dollars)

Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.2: Percentage change in Quebec NIHB expenditures (Thousands of dollars)

This image visually describes NIHB expenditures and annual percentage change in Quebec, as follows:

Quebec 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures (Hundred Thousands of dollars) $87,690 $91,831 $94,210 $96,120 $104,136 $103,773 $117,373 $128,017 $138,032 $153,872
Total benefits annual percentage change 3.6% 4.7% 2.6% 2.0% 8.3% -0.3% 13.1% 9.1% 7.8% 11.5%

Annual expenditures by benefit (Hundred Thousands of dollars)

Table 10.2: Quebec annual expenditures by benefit (Hundred Thousands of dollars)
Quebec 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $23,687 $23,501 $23,918 $24,642 $25,729 $25,379 $26,775 $28,921 $28,596 $32,649
Pharmacy $42,554 $45,554 $46,227 $46,623 $50,747 $53,282 $58,827 $64,799 $70,023 $75,758
MS&E $1,652 $1,890 $2,163 $2,345 $2,564 $2,379 $2,855 $3,149 $3,828 $4,275
Dental $16,641 $17,569 $17,961 $17,882 $18,733 $14,934 $19,092 $20,427 $23,367 $26,352
Mental health $1,148 $1,292 $1,861 $2,382 $3,138 $4,493 $5,604 $6,381 $7,404 $8,613
Vision care $1,749 $1,762 $1,819 $1,908 $2,736 $2,814 $3,938 $4,081 $4,113 $4,056
Other $258 $263 $260 $339 $490 $493 $282 $258 $700 $2,169
Total $87,690 $91,831 $94,210 $96,120 $104,136 $103,773 $117,373 $128,017 $138,032 $153,872
Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Ontario

Annual expenditures in Ontario for 2024-2025 totalled $454.0 million, an increase of 9.4% from the $414.8 million spent in 2023-2024.

Medical transportation expenditures in Ontario increased by 11.7% to $185.5 million, while pharmacy costs increased by 9.2% to $131.0 million and dental expenditures increased by 4.5% to $82.5 million. Mental health counselling expenditures increased by 13.8%, while MS&E increased by 10.7% and vision care expenditures increased by 0.7%.

Medical transportation expenditures accounted for 40.9% of total expenditures for Ontario. Pharmacy costs ranked second at 28.9%, followed by dental at 18.2%. Mental health, MS&E and vision care expenditures accounted for 6.9%, 2.9% and 2.2% of total expenditures respectively.

Chart 10.3: Percentage change in Ontario NIHB expenditures (Hundred Thousands of dollars)

Source: FST and FIRMS adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.3: Percentage change in Ontario NIHB expenditures (Hundred Thousands of dollars)

This image is a stacked bar graph which visually describes NIHB expenditures and annual percentage change in Ontario, as follows:

Ontario 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures (Hundred Thousands of dollars) $215,738 $231,663 $250,947 $269,127 $287,643 $273,987 $325,494 $365,069 $414,797 $453,992
Total benefits annual percentage change 6.3% 7.4% 8.3% 7.2% 6.9% -4.7% 18.8% 12.2% 13.6% 9.4%

Annual expenditures by benefit (Thousands of dollars)

Table 10.3: Ontario annual expenditures by benefit (Thousands of dollars)
Ontario 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $67,772 $74,890 $86,091 $98,605 $106,638 $90,646 $114,814 $140,343 $166,036 $185,502
Pharmacy $84,232 $88,466 $99,550 $100,558 $104,760 $105,300 $112,069 $113,842 $119,964 $131,045
MS&E $4,639 $5,634 $5,915 $6,662 $7,322 $7,297 $8,700 $10,045 $12,071 $13,358
Dental $49,903 $52,105 $52,055 $53,667 $55,386 $47,218 $59,326 $67,128 $78,995 $82,516
Mental health $3,021 $4,091 $6,028 $9,053 $12,116 $15,491 $21,762 $24,491 $27,432 $31,210
Vision care $6,160 $6,223 $6,848 $6,744 $7,860 $7,346 $8,113 $8,633 $9,732 $9,804
Other $11 $254 $375 $500 $883 $688 $710 $587 $567 $556
Total $215,738 $231,663 $250,947 $269,127 $287,643 $273,987 $325,494 $365,069 $414,797 $453,992
Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Manitoba

Annual expenditures in Manitoba for 2024-2025 totalled $573.2 million, an increase of 13.9% from the $503.1 million spent in 2023-2024. Medical transportation expenditures in 2024-2025 increased by 16.4% to $304.3 million, while pharmacy costs increased by 9.4% to $140.3 million. Dental expenditures increased by 14.0% to $78.6 million. Mental health counselling and MS&E expenditures increased by 17.6% and 11.2% respectively while vision care decreased by 3.9%.

Due to the higher proportion of clients living in northern or remote communities in Manitoba, medical transportation expenditures comprised more than half of total expenditures in Manitoba at 53.1%. Pharmacy costs ranked second at 24.5%, followed by dental at 13.7%. Mental health counselling, MS&E and vision care expenditures accounted for 4.1%, 3.0% and 1.4% of total expenditures respectively.

Chart 10.4: Percentage change in Manitoba NIHB expenditures ((Hundred Thousands of dollars))

Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.4: Percentage change in Manitoba NIHB expenditures (Hundred Thousands of dollars)

This image is a stacked bar graph which visually describes NIHB expenditures and annual percentage change in Manitoba, as follows:

Manitoba 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures ($M) $258,077 $291,989 $308,208 $320,953 $351,983 $337,517 $391,177 $451,799 $503,072 $573,171
Total benefits annual % change 7.9% 13.1% 5.6% 4.1% 9.7% -4.1% 15.9% 15.5% 11.3% 13.9%

Annual expenditures by benefit (Hundred Thousands of dollars)

Table 10.4: Manitoba annual expenditures by benefit (Hundred Thousands of dollars)
Manitoba 2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019 2019 to 2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $125,308 $147,167 $155,370 $156,961 $168,686 $155,794 $184,200 $233,140 $261,374 $304,285
Pharmacy $82,922 $88,639 $98,046 $101,250 $112,025 $106,851 $112,353 $120,207 $128,221 $140,287
MS&E $5,075 $6,119 $6,985 $9,166 $11,966 $11,145 $13,330 $13,870 $15,661 $17,418
Dental $36,764 $39,986 $41,949 $48,099 $52,622 $44,149 $57,381 $60,247 $68,952 $78,577
Mental health $3,780 $5,635 $8,124 $9,705 $11,475 $13,803 $16,333 $16,393 $20,003 $23,533
Vision care $4,212 $4,204 $4,479 $4,699 $6,935 $5,529 $7,334 $7,669 $8,605 $8,270
Other $17 $240 $240 $240 $240 $245 $247 $273 $255 $802
Total $258,077 $291,989 $308,208 $320,953 $351,983 $337,517 $391,177 $451,799 $503,072 $573,171
Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Saskatchewan

Annual expenditures in Saskatchewan for 2024-2025 totalled $447.4 million, an increase of 13.7% from the $393.3 million spent in 2023-2024.

NIHB pharmacy expenditures increased in Saskatchewan by 8.0% to $148.4 million, while medical transportation costs increased by 18.7% to $137.6 million. Dental cost increased by 11.4% to $87.0 million. Mental health counselling, MS&E and vision care costs increased by 10.8%, 18.4% and 7.4% respectively.

Pharmacy expenditures comprised the largest portion of total NIHB expenditures in Saskatchewan at 33.2%, medical transportation costs ranked second, at 30.8%, followed by dental at 19.4%. Mental health, MS&E and vision care expenditures accounted for 7.9%, 4.7% and 2.7% of total expenditures respectively.

Chart 10.5: Percentage change in Saskatchewan NIHB expenditures (Hundred Thousands of dollars)

Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.5: Percentage change in Saskatchewan NIHB expenditures (Hundred Thousands of dollars)

This image is a stacked bar graph which visually describes NIHB expenditures and annual percentage change in Saskatchewan, as follows:

Saskatchewan 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures (Hundred Thousands of dollars) $193,502 $220,352 $247,997 $265,082 $290,386 $286,028 $335,584 $363,319 $393,315 $447,356
Total benefits annual percentage change 7.5% 13.9% 12.5% 6.9% 9.5% -1.5% 17.3% 8.3% 8.3% 13.7%

Annual expenditures by benefit (Hundred Thousands of dollars)

Table 10.5: Saskatchewan annual expenditures by benefit (Hundred Thousands of dollars)
Saskatchewan 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $53,566 $58,902 $64,363 $75,330 $83,947 $84,951 $103,152 $114,863 $115,915 $137,570
Pharmacy $84,129 $95,937 $119,326 $118,250 $126,963 $116,188 $120,000 $126,676 $137,470 $148,399
MS&E $7,041 $8,145 $9,426 $10,762 $11,889 $11,908 $13,352 $15,310 $17,587 $20,830
Dental $41,028 $47,321 $50,635 $55,603 $57,639 $47,507 $63,408 $70,480 $78,046 $86,957
Mental health $1,631 $3,304 $6,559 $7,867 $11,783 $16,770 $24,881 $25,194 $31,869 $35,304
Vision care $6,104 $6,533 $6,905 $7,822 $9,844 $8,493 $10,581 $10,585 $11,243 $12,077
Other $4 $210 $210 $210 $210 $211 $211 $211 $1,186 $6,219
Total $193,502 $220,352 $247,997 $265,082 $290,386 $286,028 $335,584 $363,319 $393,315 $447,356
Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Alberta

Annual expenditures in Alberta for 2024-2025 totalled $316.7 million, an increase of 9.9% from the $288.1 million spent in 2023-2024. Medical transportation expenditures increased by 14.4% to $79.5 million, while pharmacy costs increased by 7.7% to $110.4 million. Dental expenditures increased by 11.2% to $82.8 million. Mental health counselling and MS&E expenditures increased by 11.7% and 2.6% while vision care expenditures decreased by 2.2%

Pharmacy expenditures accounted for 34.9% of total NIHB expenditures in Alberta. Dental costs ranked second at 26.2%, followed by medical transportation at 25.1%. Mental health counselling, MS&E and vision care expenditures accounted for 6.4%, 4.4% and 2.9% of total expenditures respectively.

Chart 10.6: Percentage change in Alberta NIHB expenditures (Hundred Thousands of dollars)

Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.6: Percentage change in Alberta NIHB expenditures (Hundred Thousands of dollars)

This image is a stacked bar graph which visually describes NIHB expenditures and annual percentage change in the Alberta region, as follows:

Alberta 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures (Hundred Thousands of dollars) $168,211 $183,108 $192,983 $209,122 $232,177 $222,953 $248,869 $271,783 $288,092 $316,744
Total benefits annual percentage change 5.8% 8.9% 5.4% 8.4% 11.0% -4.0% 11.6% 9.2% 6.0% 9.9%

Annual expenditures by benefit (Hundred Thousands of dollars)

Table 10.6: Alberta annual expenditures by benefit (Hundred Thousands of dollars)
Alberta 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $46,252 $48,157 $51,187 $56,870 $61,669 $59,492 $67,206 $71,908 $69,508 $79,500
Pharmacy $64,370 $69,362 $79,343 $83,103 $93,776 $84,920 $86,680 $96,511 $102,556 $110,449
MS&E $5,623 $7,902 $8,260 $9,127 $10,250 $9,647 $11,658 $12,503 $13,614 $13,965
Dental $39,753 $44,315 $47,637 $51,617 $54,993 $47,741 $58,790 $65,240 $74,484 $82,829
Mental health $6,003 $6,444 $7,761 $9,545 $11,020 $12,843 $14,771 $15,815 $18,216 $20,344
Vision care $6,207 $6,928 $6,764 $7,696 $10,514 $8,030 $9,405 $9,446 $9,355 $9,153
Other $3 $0 $291 $291 $204 $280 $360 $360 $360 $503
Total $168,211 $183,108 $192,983 $209,122 $232,177 $222,953 $248,869 $271,783 $288,092 $316,744
Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Northern region

Annual expenditures in the Northern region for 2024-2025 totalled $230.1 million, an increase of 3.9% from the $221.5 million spent in 2023-2024. Medical transportation expenditures decreased by 5.4% to $122.9 million while pharmacy costs increased by 12.6% to $40.4 million. Dental expenditures increased by 24.9% to $48.2 million. MS&E and vision care costs increased by 22.4% and 1.3% respectively while mental health counselling costs decreased by 2.5%

As with Manitoba, medical transportation expenditures comprised the largest portion of total NIHB expenditures in the Northern region at 53.4%. Dental costs ranked second at 20.9%, followed by pharmacy at 17.6%. MS&E, vision care and mental health counselling expenditures accounted for 3.7%, 2.2% and 2.0% of total expenditures respectively.

Chart 10.7: Percentage change in Northern region NIHB expenditures (Hundred Thousands of dollars)

Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 10.7: Percentage change in Northern region NIHB expenditures (Hundred Thousands of dollars)

This image is a stacked bar graph which visually describes NIHB expenditures and annual percentage change in the Northern region, as follows:

Northern region 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Total expenditures (Hundred Thousands of dollars) $102,040 $109,157 $126,933 $134,474 $142,961 $157,664 $162,080 $181,796 $221,469 $230,077
Total benefits annual percentage change 8.2% 7.0% 16.3% 5.9% 6.3% 10.3% 2.8% 12.2% 21.8% 3.9%

Annual expenditures by benefit (Hundred Thousands of dollars)

Table 10.7: Northern region annual expenditures by benefit (Hundred Thousands of dollars)
Northern region 2015-2016 2016-2017 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 2024-2025
Transportation $50,940 $55,125 $67,413 $70,806 $76,601 $96,194 $90,286 $103,926 $129,898 $122,868
Pharmacy $23,528 $24,283 $29,373 $31,571 $33,220 $29,479 $31,499 $33,457 $35,869 $40,397
MS&E $3,880 $4,205 $4,018 $4,529 $4,884 $4,024 $5,647 $5,520 $6,898 $8,443
Dental $20,936 $21,966 $25,141 $26,211 $26,546 $20,342 $26,830 $30,332 $38,600 $48,198
Mental health $191 $362 $1,528 $2,172 $2,167 $3,895 $3,333 $3,394 $4,711 $4,595
Vision care $2,564 $3,217 $3,131 $3,713 $3,929 $3,206 $4,081 $4,683 $5,004 $5,067
Other $1 $0 $346 $1 $498 $524 $405 $485 $490 $508
Total $102,040 $109,157 $126,933 $134,474 $142,961 $157,664 $162,080 $181,796 $221,469 $230,077
Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

11. NIHB program administration

The roles of NIHB headquarters include:

The roles of NIHB regional offices include:

Non-insured health benefits administration costs (Hundred Thousands of dollars) 2024-2025

Table 11.1 outlines program administration expenditures by region and at NIHB headquarters (HQ) costs. In 2024 to 2025, total NIHB administration costs were $93.0 million, an increase of 6.9% over the previous fiscal year.

Claims processing contract costs are related to the administration of pharmacy, medical supplies and equipment, dental benefits, mental health counselling and vision care benefits through the Health Information and Claims Processing Services (HICPS) system.

Table 11.1: NIHB program administration expenditures by region (Hundred Thousands of dollars)
Categories Atlantic Quebec Ontario Manitoba Saskatchewan Alberta North HQ Total
Salaries $2,383 $2,455 $6,552 $5,901 $5,170 $5,437 $2,153 $24,107 $54,158
EBP $639 $657 $1,751 $1,593 $1,390 $1,460 $578 $6,488 $14,555
Operating $66 $27 $144 $107 $139 $104 $58 $2,492 $3,136
Subtotal $3,088 $3,140 $8,446 $7,601 $6,698 $7,001 $2,789 $33,087 $71,849
Claims processing contract costs $21,112
Total administration costs $92,961
Source: FST adapted by Program Analytics and Risk Mitigation

Non-Insured Health Benefits administration costs as a proportion of benefit expenditures ($ millions)

In 2024-2025, total NIHB benefit expenditures were $2,330.7 million, of which direct benefit expenditures totalled $2,309.57 million and expenditures for claims processing administration amounted to $21.1 million. An additional $71.8 million was spent on salaries and operating costs associated with program administration. Some administrative costs paid within contribution agreements are not captured in these data.

Total NIHB program administration costs ($93.0 million, including claims processing and other program administration) as a proportion of direct benefit expenditures ($2.3 billion) was 4.0% in 2024-2025. Over the past 5 fiscal years, the percentage of NIHB program administration costs as a proportion of total benefit expenditures has ranged from a high of 5.0% in 2020-2021 to a low of 3.9% in 2022-2023.

Chart 11.1: Non-Insured Health Benefits administration costs as a proportion of benefit expenditures ($ millions)

Source: FST and FIRMS, adapted by Program Analytics and Risk Mitigation

Text alternative for Chart 11.1: Non-Insured Health Benefits administration costs as a proportion of benefit expenditures ($ millions)

This image is a bar graph which visually describes NIHB program expenditures and the percentage of which are administrative costs, as follows:

Fiscal year NIHB benefit expenditures ($ millions) Percentage administrative costs
2020-2021 $1,490.6 5.0%
2021-2022 $1,695.3 4.2%
2022-2023 $1,891.7 3.9%
2023-2024 $2,098.1 4.2%
2024-2025 $2,330.7 4.0%

Health Information and Claims Processing Services 2024-2025

Claims for NIHB pharmacy, dental, MS&E, as well as most mental health counselling and vision care benefits provided to eligible First Nations and Inuit clients are processed via the Health Information and Claims Processing Services (HICPS) system. HICPS includes administrative services and programs, technical support and automated information management systems that are used to process and pay claims in accordance with NIHB program client or benefit eligibility and pricing policies.

Since 1990, the NIHB program has retained the services of a private sector contractor to administer the following core claims processing services on its behalf:

  • claim processing and payment operations
  • claim adjudication and reporting systems development and maintenance
  • provider registration and communications
  • provider audit programs and audit recoveries
  • standard and ad hoc reporting

The current HICPS contract is with Express Scripts Canada. This contract came into force on June 28, 2020, following a competitive contracting process led by Public Services and Procurement Canada (PSPC). The NIHB program manages the HICPS contract as the project authority in conjunction with PSPC, the contract authority.

Number of active providers registered in the Health Information and Claims Processing Services system 2024-2025

Benefit providers can register with Express Scripts Canada to provide benefits to NIHB clients and bill the program directly. An active provider is a provider who is registered and has submitted at least 1 claim in the 24 months prior to March 31, 2025.

As of March 31, 2025, there were 47,242 active pharmacy, dental, MS&E, mental health counselling and vision care providers. The number of active providers by region and by benefit is outlined in the table below.

Table 11.2: Number of NIHB providers by region and benefit April 2023 to March 2025
Region Pharmacy MS&E Dental Vision care Mental health counselling
Atlantic 945 298 1,428 583 515
Quebec 2,156 293 3,579 449 991
Ontario 5,160 993 9,135 2,116 1,804
Manitoba 574 110 1,290 452 199
Saskatchewan 518 173 935 747 357
Alberta 1,974 437 4,413 894 1,071
British Columbia 1,057 43 854 10 68
North 35 33 469 54 30
Total 12,419 2,380 22,103 5,305 5,035
Source: HICPS adapted by Program Analytics and Risk Mitigation

Number of claim lines settled through the Health Information and Claims Processing Services system 2024-2025

During 2024-2025, more than 36 million claim lines for pharmacy, dental, MS&E, vision care and mental health counselling benefits were processed through HICPS. Ontario had the highest volume of claims processed at 9.1 million, followed by Alberta at 7.5 million and Manitoba at 6.8 million.

Claim lines vs. prescriptions or visits

The program reports annually on claim lines. This is an administrative unit of measure as opposed to a health care unit of measure. A claim line represents a transaction in the claims processing system and is not equivalent to a prescription or health practitioner visit. Prescriptions can contain several different drugs with each one represented by a separate claim line. Prescriptions for a number of drugs may be repeated and refilled many times throughout the year. In the case of repeating prescriptions, each time a prescription is refilled, the system will log another transaction (claim line). Therefore, it is possible for an individual who has a prescription that repeats multiple times in a year to have numerous related claim lines associated with the single prescription. Likewise, an appointment with a medical practitioner may result in multiple claim lines as several procedures are performed at the same visit.

Mental health counselling services for clients in Nunavut and the Northwest Territories are funded via contribution agreements. Claim lines are not captured in the HICPS system for those territories.

Table 11.3: Number of claim lines processed through HICPS by region and benefit
Region Pharmacy Dental MS&E Mental health Vision care Total
Atlantic 2,004,238 218,340 62,250 40,024 30,820 2,355,672
Quebec 3,876,430 237,110 57,103 27,008 22,203 4,219,854
Ontario 7,933,785 873,076 85,294 189,175 55,146 9,136,476
Manitoba 5,766,174 739,900 147,269 57,626 43,158 6,754,127
Saskatchewan 4,493,337 641,197 163,262 121,732 73,868 5,493,396
Alberta 6,194,936 1,043,260 115,190 91,455 67,303 7,512,144
British Columbia 63,491 14,021 394 235 345 78,486
North 888,035 249,499 42,315 6,482 11,327 1,197,658
Total claim lines 31,225,743 4,029,289 673,142 533,737 304,170 36,766,081
Source: HICPS adapted by Program Analytics and Risk Mitigation

Claims verification activities 2024-2025

As part of risk management activities for the NIHB program, Indigenous Services Canada mandates its claims processor to maintain a set of pre-payment and post-payment processes, including claims verification activities.

During 2024-2025, the claims processor carried out claims verifications as directed by the NIHB program. These verifications address the need of the NIHB program to comply with accountability requirements for the use of public funds and to ensure provider compliance with the terms and conditions of the program as outlined in the appropriate NIHB Benefit Guide, Claims Submission Kit, Provider Billing Agreement and other relevant documents.

There are 5 components within claims verification activities for the pharmacy, medical supplies and equipment, dental benefit, vision care, and mental health counselling areas. These are:

  • Daily Claim Verification Program consists of a review of a defined sample of claims submitted by providers the day following receipt by the claims processor
  • Client Confirmation Program consists of a monthly mail-out to NIHB clients to confirm the receipt of services that have been paid on their behalf
  • On-Site Claim Verification Program consists of the selection of a sample of claims for administrative validation against a provider's records through an on-site visit
  • Desk Claim Verification Program consists of the selection of a sample of claims for administrative validation against a provider's records and conducted at a distance
  • Financial Recovery Program consists of a focused recovery assessment

The following figure identifies recoveries from all components of the claims verification process during the 2023-2024 fiscal year.

Completion of a verification process often spans more than 1 fiscal year. Recoveries from claims verification activities are recorded in the fiscal year in which they are received. Subsequent appeals to reversals may result in claim payment if confirmed services comply with the terms and conditions of the NIHB Program.

Table 11.4: Claim verification recoveries by region
Region Pharmacy recoveries Dental recoveries MS&E recoveries Vision care recoveries Mental health counselling recoveries
Atlantic $0 $0 $9,316 $0 $0
Quebec $112,039 $0 $31,931 $0 $0
Ontario $0 $2,251 $23,916 $0 $126,383
Manitoba $49,122 $29,544 $173,770 $0 $0
Saskatchewan $17,343 $10,713 $21,779 $190 $75,763
Alberta $0 $26,940 $23,946 $0 $0
British Columbia $0 $0 $0 $0 $0
Yukon $0 $1,280 $0 $0 $0
N.W.T. $0 $0 $0 $0 $0
Nunavut $0 $0 $0 $0 $0
Total $178,505 $70,728 $284,659 $190 $202,146
Source: Express Scripts Canada adapted by Program Analytics and Risk Mitigation

12. NIHB partnership initiatives

In line with Canada's commitments under the United Nations Declaration of the Rights of Indigenous Peoples and the Truth and Reconciliation Commission's Calls to Action, Indigenous Services Canada works with Indigenous organizations including the Assembly of First Nations and the Inuit Tapiriit Kanatami, to advance shared priorities focused on improving health outcomes for First Nations and Inuit.

Collaboration with First Nations and Inuit partners

Indigenous Services Canada (ISC) is engaged in a multi-year joint review of the NIHB program in partnership with the Assembly of First Nations (AFN). The overall objectives of the review are to identify and implement actions that enhance client access to benefits, identify gaps in benefits, streamline service delivery to be more responsive to client needs, and increase program efficiencies. The AFN conducted a robust program of client, provider and stakeholder engagement activities to gather broad input and perspectives that will inform recommendations for program improvements. The joint review is guided by a Steering Committee comprised of First Nations and ISC representatives.

As of March 31, 2024, joint reviews of the mental health counselling, dental, vision care, pharmacy and medical supplies and equipment benefits are complete and the review of the medical transportation benefit is in progress. Meanwhile, the NIHB Program continues to implement many improvements to benefit coverage and administration. For more information on the Non-insured Health Benefits program joint review, including highlights of changes and improvements made by NIHB throughout the process, visit us on the web.

Indigenous Services Canada continues to work with the Inuit Tapiriit Kanatami (ITK) to improve the quality, access, and delivery of NIHB benefits to Inuit clients. NIHB and ITK representatives meet regularly to discuss issues of concern and identify opportunities for improvement. In January 2023, NIHB and ITK established a new engagement table including representatives of the National Inuit Committee on Health to discuss priorities and concerns for Inuit NIHB clients. NIHB shares information and regularly updates Inuit partners on progress made to advance priorities identified by Inuit partners.

Client and provider communications

NIHB is continually seeking ways to improve communications with clients, providers and partners regarding benefit coverage and administration.

The NIHB program regularly produces newsletters and updates to inform clients and providers about any changes to NIHB policy and benefit coverage. For example, NIHB enrolled providers for dental, pharmacy, MS&E, vision care and mental health counselling receive notification of policy updates and relevant information regarding benefits through regular provider newsletters, periodic bulletins and broadcast messages.

These communications are distributed to enrolled providers by Express Scripts Canada (ESC), Indigenous Services Canada's claims processing contractor, and are available via the ESC website at: nihb.express-scripts.ca.

The Government of Canada website is a key venue for sharing NIHB program information to clients. NIHB program updates are produced quarterly and as needed to provide information for clients regarding changes to benefit coverage. Clients can subscribe to receive email notifications when these updates are published, and those who have set up web accounts through Express Scripts Canada also receive notification of new updates. Client-focused communications are also promoted through social media on the Government of Canada's Healthy First Nations and Inuit Facebook page and GCIndigenous X (formerly called Twitter) account. Additional social media posts promote client awareness of benefit coverage, often in conjunction with broader public health promotion campaigns. For example, a post on diabetes awareness will include a reminder about NIHB coverage of diabetes medications and supplies, and a post on vision health may include a reminder about NIHB coverage of eye exams.

NIHB strives to be accessible and responsive to clients. Clients can contact NIHB directly by calling Indigenous Services Canada regional offices, the NIHB Dental Predetermination Centre, or the NIHB Drug Exception Centre. The Contact us web page for the NIHB program also provides an email address for direct inquiries to the NIHB program.

NIHB Navigators

NIHB Navigators help eligible clients to navigate and access the NIHB program. They are a resource for communities, organizations or individuals who need support or information on NIHB-related issues. Navigators are employed by regional First Nations and Inuit organizations. Their roles and activities are adapted to meet regional needs and generally include the following:

  • increase understanding of the NIHB program and share information on eligible benefits
  • help clients and communities to resolve NIHB-related issues
  • link with health departments and agencies to help improve client access to NIHB benefits and related health services

NIHB program representatives regularly engage with Navigators and support them in their work by sharing program information, responding to inquiries and assisting with client cases. Navigators also provide valuable support to the program by sharing their insight on client experiences and working collaboratively to improve client-focused service.

NIHB drug benefit listing and review

The NIHB Drug Benefits List (DBL) is a listing of all of the drugs provided as benefits by the NIHB program. Drugs considered for, or currently listed on, the DBL must meet established criteria. For example, they must be legally available for sale in Canada with a Notice of Compliance (NOC) and Drug Identification Number (DIN) or Natural Product Number (NPN) and be dispensed in a pharmacy. The drugs must also demonstrate evidence of therapeutic efficacy, safety and incremental benefit in proportion to incremental cost.

The review process for drug products that are considered for inclusion as a benefit under the NIHB program varies depending on the type of drug submitted. Submissions for new chemical entities, new combination drug products and existing chemical entities with new indications, must be sent to Canada's Drug Agency (CDA-AMC), an independent organization that provides research and information about the effectiveness of drugs and other medical treatments.

Through the Reimbursement Reviews and Recommendations process and pan-Canadian Oncology Drug Review (pCODR), CDA-AMC evaluates the clinical, economic and patient evidence on drugs and medical technologies. Based on this information, CDA-AMC expert committees provide coverage recommendations and advice to Canada's public drug plans, including the NIHB program. These processes were established by federal, provincial and territorial public drug plans to reduce duplication of effort in reviewing drug submissions, to maximize the use of resources, and to enhance the consistency of drug reviews.

NIHB Drugs and Therapeutics Advisory Committee

The NIHB Drugs and Therapeutics Advisory Committee (DTAC) is an advisory body of highly qualified health professionals who bring impartial and practical expert medical and pharmaceutical advice to the NIHB program to promote improvement in the health outcomes of First Nations and Inuit clients through effective use of pharmaceuticals. The approach is evidence-based and the advice reflects medical and scientific knowledge, current utilization trends, current clinical practice, health care delivery and client healthcare needs.

More information on DTAC and its members

NIHB Oral Health Advisory Committee

The NIHB Oral Health Advisory Committee (NOHAC) is an independent advisory body of highly qualified oral health professionals and academic specialists. They bring impartial and practical expert views, advice and recommendations to the NIHB program to support the improvement of oral health outcomes for First Nations and Inuit clients. The advice and recommendations provided by the Committee follow an evidence-based approach and reflect scientific knowledge, as well as clinical and oral health care delivery and disease prevention best practices.

More information on NOHAC and its members

NIHB Medical Supplies and Equipment Advisory Committee

The NIHB Medical Supplies and Equipment Advisory Committee (MSEAC) is a multidisciplinary advisory committee of highly qualified health professionals and academic specialists who bring evidence-informed impartial and practical expert advice and recommendations to the NIHB program regarding both medical supplies and equipment and vision care benefits. The approach reflects medical and scientific knowledge, current utilization trends, current clinical practice, health care delivery and client healthcare needs and is intended to promote improvement in the health outcomes of First Nations and Inuit clients.

Drug Exception Centre

The Drug Exception Centre (DEC) is a call centre that provides efficient responses to all requests for drugs that are not on the NIHB Drug Benefit List or require prior approval, for extemporaneous mixtures containing exception or Limited Use (LU) drugs, for prescriptions on which prescribers have indicated no substitution and for claims that exceed $1,999.99.

The DEC also supports the implementation of the Problematic Substance Use Strategy to address and prevent potential misuse of prescription drugs. The program has set limits on medications of concern and developed a structured approach towards client safety which includes the implementation of the Client Safety Program across the country.

Dental Predetermination Centre

The Dental Predetermination Centre (DPC) is a call centre that provides efficient adjudication of all dental and orthodontic predetermination requests, post-determination requests and appeals. In addition, the DPC is responsible for addressing client and provider inquiries and for assisting clients and providers with the submission of the predetermination, post-determination, client reimbursement and appeal requests.

Medical Supplies and Equipment Review Centre

NIHB staff at the regional level manage prior approval of medical supplies and equipment benefit requests, with support from the MS&E Review Centre (MSERC) at the NIHB national office. The MSERC is staffed in-house by various health professionals, including registered nurses. In cases where advice is required by a particular specialist, such as an audiologist or an orthotist, information is forwarded to the appropriate specialist consultant for review. Consultants make their recommendations based upon the current standards of practice, best practices, current scientific evidence, program policy and recommended guidelines within their field of specialty.

13. Technical notes

Information contained in the 2024-2025 NIHB Annual Report has been extracted from several databases. All tables and charts are footnoted with the appropriate data sources. These data sources are considered to be of very high quality but, as in any administrative data set, some data may be subject to coding errors or other anomalies. For this reason, users of the data should always refer to the most current edition of the NIHB Annual Report. Please note that some table totals may not add due to rounding procedures.

To address reporting challenges related to NIHB clients registered to British Columbia bands but living elsewhere, and Inuit clients living in BC, select financial and utilization data relating to the British Columbia Region have been suppressed. National totals, however, include these values.

To address reporting challenges related to the small number of NIHB clients choosing a non-binary gender designation at this time and in keeping with government practices for safeguarding the privacy of individuals and in respect of departmental privacy obligations, population and utilization data relating to individuals in the category Another gender have been distributed into the other 2 gender categories and are denoted by the + symbol.

Starting in 2020-2021, expenditures for the NIHB MS&E benefit are being reported separately from NIHB pharmacy benefit expenditures. As such, historical values reported for NIHB pharmacy will not match those reported in previous editions as those values included MS&E.

Starting in 2023-2024, expenditures relating to administration of the HICPS contract are being reporting only at the program level. As such, historical values reported for individual benefits will not match those reported in previous editions of the NIHB Annual Report.

Population data

First Nations and Inuit population data are drawn from the Status Verification System (SVS), which is operated by NIHB. SVS data on First Nations clients are based on information provided by the Registrar's office of Indigenous Services Canada. SVS data on Inuit clients are based on information provided by the Governments of Northwest Territories and Nunavut, and Inuit land claim organizations including the Inuvialuit Regional Corporation, Nunavut Tunngavik Incorporated and the Makivik Corporation.

Pharmacy, MS&E, dental, mental health counselling and vision care data

Two Indigenous Services Canada data systems provide information on the expenditures and utilization of the NIHB pharmacy, MS&E, dental, vision care and mental health counselling benefits. Financial Services and Training (FST) is the source of most expenditure data, while the Health Information and Claims Processing Services system provides detailed information on utilization. Expenditure data prior to fiscal year 2019-2020 were collected from the Framework for Integrated Resource Management System.

Medical transportation data

Medical transportation financial data are provided through FST. Medical transportation data are also collected regionally through other electronic systems. Operational data at the regional level are tracked through the Medical Transportation Reporting System (MTRS). Contribution agreement data are also collected, but in a limited manner. In some communities, MTRS is used to collect contribution agreement data, while other communities report data using spreadsheet templates, in-house data management systems, or through paper reports.

The Medical Transportation Data Store serves as a repository for limited operational data, as well as the data collected from medical transportation contribution agreements and ambulance data systems.

Did you find what you were looking for?

What was wrong?

You will not receive a reply. Don't include personal information (telephone, email, SIN, financial, medical, or work details).
Maximum 300 characters

Thank you for your feedback

Date modified: